TW201500463A - Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element Download PDF

Info

Publication number
TW201500463A
TW201500463A TW103106758A TW103106758A TW201500463A TW 201500463 A TW201500463 A TW 201500463A TW 103106758 A TW103106758 A TW 103106758A TW 103106758 A TW103106758 A TW 103106758A TW 201500463 A TW201500463 A TW 201500463A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
formula
treatment agent
alignment treatment
Prior art date
Application number
TW103106758A
Other languages
Chinese (zh)
Other versions
TWI617622B (en
Inventor
Naho Kikuchi
Daisuke Sakuma
Koji Tomoe
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201500463A publication Critical patent/TW201500463A/en
Application granted granted Critical
Publication of TWI617622B publication Critical patent/TWI617622B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D179/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen, with or without oxygen, or carbon only, not provided for in groups C09D161/00 - C09D177/00
    • C09D179/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C09D179/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

Provided is a liquid crystal alignment agent that contains at least one polymer chosen from among a polyimide precursor and a polyimide obtained by imidization of the polyimide precursor, the polyimide precursor being obtained by reacting a diamine component with a tetracarboxylic acid component that includes a tetracarboxylic acid dianhydride represented by formula [1] and an aliphatic tetracarboxylic acid dianhydride represented by formula [2]. (In formula [2], Z1 is at least one tetravalent group chosen from formulas [2a] through [2j].) (In formula [2a], Z2 through Z5 indicate a chlorine atom, a methyl group, a nitrogen atom, or a benzene ring, each of which can be the same or different; and in formula [2g], Z6 and Z7 indicate a hydrogen atom or a methyl group, each of which can be the same or different).

Description

液晶配向處理劑、液晶配向膜及液晶顯示元件 Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element

本發明為有關製造液晶顯示元件時所使用之液晶配向處理劑、由此液晶配向處理劑所得之液晶配向膜及使用此液晶配向膜的液晶顯示元件。 The present invention relates to a liquid crystal alignment treatment agent used in the production of a liquid crystal display device, a liquid crystal alignment film obtained by the liquid crystal alignment treatment agent, and a liquid crystal display element using the liquid crystal alignment film.

目前,液晶顯示元件之液晶配向膜,主要是作為所謂聚醯亞胺系之液晶配向膜使用,該液晶配向膜係塗佈以聚醯胺酸等之聚醯亞胺前驅物或可溶性聚醯亞胺之溶液作為主成分之液晶配向處理劑,經燒成者。 At present, a liquid crystal alignment film of a liquid crystal display element is mainly used as a so-called polyimine-based liquid crystal alignment film which is coated with a polyimine precursor such as polylysine or a soluble polyazide. A solution of an amine as a main component of a liquid crystal alignment treatment agent, which is fired.

液晶配向膜係以控制液晶之配向狀態為目的所使用之物品。但是伴隨液晶顯示元件之高精細化,就抑制液晶顯示元件之對比之降低或降低殘影現象之觀點,其所使用之液晶配向膜中,電壓保持率較高或於施加直流電壓時蓄積電荷較少或因直流電壓所蓄積之電荷之緩和較快等特性,已逐漸變得更為重要。 The liquid crystal alignment film is an article used for the purpose of controlling the alignment state of the liquid crystal. However, with the high definition of the liquid crystal display element, the viewpoint of suppressing the decrease in the contrast of the liquid crystal display element or reducing the image sticking phenomenon is adopted, and the liquid crystal alignment film used has a high voltage holding ratio or a charge accumulated when a DC voltage is applied. It is becoming more and more important that characteristics such as less or faster mitigation of the charge accumulated by the DC voltage.

聚醯亞胺系之液晶配向膜中,因直流電壓所發生之殘影至消失為止時間較短者,例如有使用含有聚醯胺酸或含醯亞胺基之聚醯胺酸及特定結構之3級胺的液晶 配向處理劑者(例如,參照專利文獻1),或使用含有以具有吡啶骨架等之特定二胺作為原料使用之可溶性聚醯亞胺的液晶配向處理劑者(例如,參照專利文獻2)等已為人知。又,電壓保持率高,且因直流電壓所發生之殘影至消失為止之時間較短者,例如有使用除含有聚醯胺酸或其醯亞胺化聚合物等以外,尚含有極少量之由分子內含有1個羧酸基之化合物、分子內含有1個羧酸酐基之化合物及分子內含有1個3級胺基之化合物所選出之化合物的液晶配向處理劑(例如,參照專利文獻3)已為人知。 In a polyimine-based liquid crystal alignment film, a time period from the occurrence of a residual voltage due to a DC voltage to a disappearance is, for example, a polyaminic acid containing a polyaminic acid or a quinone imine group and a specific structure are used. 3-grade amine liquid crystal The liquid crystal alignment treatment agent (for example, refer to Patent Document 1), or a liquid crystal alignment treatment agent containing a soluble polyimine which is used as a raw material having a specific diamine such as a pyridine skeleton (for example, see Patent Document 2) Known. Further, the voltage holding ratio is high, and the time period from the occurrence of the residual image due to the DC voltage to the disappearance is, for example, a small amount is contained in addition to the polyamine or the quinone imidized polymer. A liquid crystal alignment treatment agent containing a compound having one carboxylic acid group in the molecule, a compound having one carboxylic acid anhydride group in the molecule, and a compound having one amino acid group in the molecule (for example, refer to Patent Document 3) ) is already known.

[先前技術文獻] [Previous Technical Literature] [專利文獻] [Patent Literature]

[專利文獻1]日本特開平9-316200號公報 [Patent Document 1] Japanese Patent Laid-Open Publication No. Hei 9-316200

[專利文獻2]日本特開平10-104633號公報 [Patent Document 2] Japanese Patent Laid-Open No. Hei 10-104633

[專利文獻3]日本特開平8-076128號公報 [Patent Document 3] Japanese Patent Laid-Open No. Hei 8-076128

[發明概要] [Summary of the Invention]

近年隨著液晶顯示元件之高性能化,在大畫面且具有高精細度之液晶電視、車載用途,例如汽車導航系統或儀表面板等用途使用液晶顯示元件。此等用途為了得到高亮度時,有時使用發熱量較大的背光。因此,液晶 配向膜要求其他觀點的高信賴性,即對於來自背光之光的高安定性。特別是液晶顯示元件之電氣特性之一的電壓保持率,因來自背光之光照射而降低時,會產生液晶顯示元件之顯示不良之一的殘影不良(也稱為線殘影)的問題。 In recent years, with the increase in the performance of liquid crystal display elements, liquid crystal display elements have been used for liquid crystal televisions having large screens and high definition, and for automotive applications such as car navigation systems or instrument panels. For such applications, in order to obtain high brightness, a backlight having a large amount of heat may be used. Therefore, liquid crystal The alignment film requires high reliability from other viewpoints, that is, high stability to light from the backlight. In particular, when the voltage holding ratio of one of the electrical characteristics of the liquid crystal display element is lowered by the light irradiation from the backlight, there is a problem of image sticking failure (also referred to as line residual image) which is one of display failures of the liquid crystal display element.

因此,液晶配向膜除了初期特性良好外,也要求例如處於長時間光照射後,電壓保持率也不易降低。 Therefore, in addition to the initial characteristics of the liquid crystal alignment film, it is required that, for example, after a long period of light irradiation, the voltage holding ratio is not easily lowered.

因此,本發明之目的係提供即使長時間光照射後,也可抑制電壓保持率之降低,可得到耐光性優異之液晶配向膜的液晶配向處理劑、液晶配向膜及具有該液晶配向膜之液晶顯示元件。 Therefore, the object of the present invention is to provide a liquid crystal alignment treatment agent, a liquid crystal alignment film, and a liquid crystal having the liquid crystal alignment film, which can suppress a decrease in voltage holding ratio even after long-time light irradiation, and which can provide a liquid crystal alignment film having excellent light resistance. Display component.

本發明人精心研究結果,發現含有選自使含有特定結構之2種四羧酸二酐的四羧酸成分與二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種的聚合物的液晶配向處理劑,可非常有效地達成上述目的,遂完成本發明。 As a result of intensive studies, the present inventors have found that a polyimine precursor obtained by reacting a tetracarboxylic acid component containing two kinds of tetracarboxylic dianhydrides having a specific structure with a diamine component and a precursor of the polyimine The liquid crystal alignment treatment agent of at least one polymer of at least one type of polyimine obtained by ruthenium imidation can achieve the above object very effectively, and the present invention has been completed.

即,本發明具有以下技術特徵者。 That is, the present invention has the following technical features.

(1)一種液晶配向處理劑,其特徵係含有選自使含有以下述式[1]表示之四羧酸二酐及下述式[2]表示之四羧酸二酐的四羧酸成分與二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種的聚合物。 (1) A liquid crystal alignment treatment agent characterized by containing a tetracarboxylic acid component selected from the group consisting of a tetracarboxylic dianhydride represented by the following formula [1] and a tetracarboxylic dianhydride represented by the following formula [2] A polymer obtained by reacting a polyimine component obtained by reacting a diamine component with at least one polymer obtained by subjecting the polyimine precursor to ruthenium imidization.

(式[2]中,Z1係選自下述式[2a]~式[2j]之至少一種的4價基)。 (In the formula [2], Z 1 is selected from a tetravalent group of at least one of the following formulas [2a] to [2j]).

(式[2a]中,Z2~Z5表示氫原子、甲基、氯原子或苯環,各自可相同或相異;式[2g]中,Z6及Z7表示氫原子或甲基,各自可相同或相異)。 (In the formula [2a], Z 2 to Z 5 represent a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and each may be the same or different; in the formula [2g], Z 6 and Z 7 represent a hydrogen atom or a methyl group, Each can be the same or different).

(2)如前述(1)項之液晶配向處理劑,其係含有N-甲基-2-吡咯烷酮(pyrrolidone)、N-乙基-2-吡 咯烷酮或γ-丁內酯作為液晶配向處理劑中之溶劑。 (2) The liquid crystal alignment treatment agent according to the above (1), which comprises N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ -butyrolactone as a liquid crystal alignment treatment agent. Solvent.

(3)如前述(1)或(2)項之液晶配向處理劑,其係含有選自下述式[D-1]~式[D-3]的溶劑作為液晶配向處理劑中之溶劑, (式[D-1]中,D1表示碳數1~3之烷基,式[D-2]中,D2表示碳數1~3之烷基,式[D-3]中,D3表示碳數1~4之烷基)。 (3) The liquid crystal alignment treatment agent according to the above (1) or (2), which contains a solvent selected from the following formula [D-1] to formula [D-3] as a solvent in the liquid crystal alignment treatment agent, (In the formula [D-1], D 1 represents an alkyl group having 1 to 3 carbon atoms, and in the formula [D-2], D 2 represents an alkyl group having 1 to 3 carbon atoms, and in the formula [D-3], D 3 represents an alkyl group having 1 to 4 carbon atoms).

(4)一種液晶配向膜,其特徵係使用如前述(1)~(3)項之液晶配向處理劑所得者。 (4) A liquid crystal alignment film which is obtained by using the liquid crystal alignment treatment agent of the above items (1) to (3).

(5)一種液晶配向膜,其特徵係使用如前述(1)~(3)項之液晶配向處理劑,藉由噴墨法所得者。 (5) A liquid crystal alignment film characterized by using the liquid crystal alignment treatment agent of the above (1) to (3), which is obtained by an inkjet method.

(6)一種液晶顯示元件,其特徵係具有如前述(4)或(5)項之液晶配向膜者。 (6) A liquid crystal display element characterized by having the liquid crystal alignment film of the above (4) or (5).

依據本發明之液晶配向處理劑時,可得到即使長時間光照射後,也可抑制電壓保持率之降低,可得到耐光性優異之液晶配向膜。因此,具有由本發明之液晶配向處理劑所得之液晶配向膜的液晶顯示元件,其信賴性優 異,可適用於大畫面且高精細的液晶電視等。 According to the liquid crystal alignment treatment agent of the present invention, it is possible to obtain a liquid crystal alignment film which is excellent in light resistance by suppressing a decrease in voltage holding ratio even after long-time light irradiation. Therefore, the liquid crystal display element having the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention has excellent reliability. Different, it can be applied to large-screen and high-definition LCD TVs.

[實施發明的形態] [Formation of the Invention]

本發明之液晶配向處理劑係含有選自使含有以下述式[1]表示之四羧酸二酐(也稱為特定四羧酸二酐)及下述式[2]表示之脂肪族四羧酸二酐(也稱為特定脂肪族四羧酸二酐)的四羧酸成分與二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種的聚合物(也稱為特定聚合物)者。 The liquid crystal alignment treatment agent of the present invention contains an aliphatic tetracarboxylic acid selected from the group consisting of tetracarboxylic dianhydride (also referred to as specific tetracarboxylic dianhydride) represented by the following formula [1] and the following formula [2]. a polyimine precursor obtained by reacting a tetracarboxylic acid component of an acid dianhydride (also referred to as a specific aliphatic tetracarboxylic dianhydride) with a diamine component, and a ruthenium imidization of the polyimine precursor A polymer (also referred to as a specific polymer) of at least one type of polyimine.

二胺成分係指分子內具有2個1級或2級胺基的二胺化合物。聚醯亞胺前驅物係指聚醯胺酸或聚醯胺酸烷酯。 The diamine component refers to a diamine compound having two primary or secondary amine groups in the molecule. Polyimine precursor refers to polyamic acid or polyalkyl amide.

<特定四羧酸二酐> <Specific tetracarboxylic dianhydride>

本發明之液晶配向處理劑所含有之特定聚合物原料的四羧酸成分係含有2種類的四羧酸二酐。其中一種類的四羧酸二酐係以下述式[1]表示之特定四羧酸二酐。 The tetracarboxylic acid component of the specific polymer raw material contained in the liquid crystal alignment treatment agent of the present invention contains two types of tetracarboxylic dianhydride. One of the tetracarboxylic dianhydrides is a specific tetracarboxylic dianhydride represented by the following formula [1].

式[1]表示之特定四羧酸二酐可使用其四羧酸衍生物之四羧酸、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物(有時全部統稱為 特定四羧酸成分)。 The specific tetracarboxylic dianhydride represented by the formula [1] may be a tetracarboxylic acid, a tetracarboxylic acid dihalide compound, a dicarboxylic acid dialkylate compound or a dicarboxylic acid dialkyl ester dihalide of a tetracarboxylic acid derivative thereof. Compounds (sometimes collectively referred to as Specific tetracarboxylic acid component).

式[1]表示之特定四羧酸二酐,較佳為全四羧酸成分中之20莫耳%~80莫耳%。其中較佳為20莫耳%~60莫耳%。特佳為20莫耳%~50莫耳%。 The specific tetracarboxylic dianhydride represented by the formula [1] is preferably 20 mol% to 80 mol% in the tetracarboxylic acid component. Of these, it is preferably from 20 mol% to 60 mol%. It is particularly good for 20% by mole to 50% by mole.

<特定脂肪族四羧酸二酐> <Specific aliphatic tetracarboxylic dianhydride>

本發明之液晶配向處理劑所含有之特定聚合物原料的四羧酸成分,含有2種類的四羧酸二酐。另外一種類的四羧酸二酐係以下述式[2]表示之特定脂肪族四羧酸二酐。 The tetracarboxylic acid component of the specific polymer raw material contained in the liquid crystal alignment treatment agent of the present invention contains two types of tetracarboxylic dianhydride. Another type of tetracarboxylic dianhydride is a specific aliphatic tetracarboxylic dianhydride represented by the following formula [2].

式[2]中,Z1係選自下述式[2a]~式[2j]之至少1種的4價基。 In the formula [2], Z 1 is a tetravalent group selected from at least one of the following formulas [2a] to [2j].

式[2a]中,Z2~Z5表示氫原子、甲基、氯原子或苯環,各自可相同或相異。 In the formula [2a], Z 2 to Z 5 represent a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and each may be the same or different.

式[2g]中,Z6及Z7表示氫原子或甲基,各自可相同或相異。 In the formula [2g], Z 6 and Z 7 represent a hydrogen atom or a methyl group, and each may be the same or different.

式[2]表示的結構中,Z1從合成之容易度或製造聚合物時之聚合反應性之容易度的觀點,較佳為式[2a]、式[2c]、式[2d]、式[2e]、式[2f]或式[2g]表示之結構。更佳為式[2a]、式[2e]、式[2f]或式[2g]表示之結構,特佳為式[2e]、式[2f]或式[2g]。 In the structure represented by the formula [2], Z 1 is preferably a formula [2a], a formula [2c], a formula [2d], or a formula from the viewpoint of easiness of synthesis or easiness of polymerization reactivity in producing a polymer. [2e], the structure represented by the formula [2f] or the formula [2g]. More preferably, it is a structure represented by the formula [2a], the formula [2e], the formula [2f] or the formula [2g], and particularly preferably the formula [2e], the formula [2f] or the formula [2g].

式[2]表示之特定脂肪族四羧酸二酐可使用其四羧酸衍生物之四羧酸、四羧酸二鹵化物化合物、四羧酸二烷酯化合物或四羧酸二烷酯二鹵化物化合物(有時全部統稱為特定四羧酸成分)。 The specific aliphatic tetracarboxylic dianhydride represented by the formula [2] may be a tetracarboxylic acid, a tetracarboxylic acid dihalide compound, a dicarboxylic acid dialkylate compound or a dicarboxylic acid dialkyl ester of the tetracarboxylic acid derivative thereof. Halide compounds (sometimes collectively referred to collectively as specific tetracarboxylic acid components).

式[2]表示之特定脂肪族四羧酸二酐,較佳為全四羧酸成分中之20莫耳%~80莫耳%。特佳為20莫耳%~60莫耳%。 The specific aliphatic tetracarboxylic dianhydride represented by the formula [2] is preferably 20 mol% to 80 mol% in the total tetracarboxylic acid component. Very good is 20% to 60% by mole.

又,特定脂肪族四羧酸二酐,配合本發明之液晶配向處理劑所含有之特定聚合物對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜時之液晶之配向性、電壓保持率、蓄積電荷等的特性,可以1種類或混合2種類以上使用。 Further, the specific aliphatic tetracarboxylic dianhydride is blended with a solvent of a specific polymer contained in the liquid crystal alignment agent of the present invention, or a coating property of a liquid crystal alignment agent, and a liquid crystal alignment property as a liquid crystal alignment film. The characteristics such as the voltage holding ratio and the accumulated electric charge can be used in one type or in a mixture of two or more types.

<其他的四羧酸化合物> <Other tetracarboxylic acid compounds>

本發明之液晶配向處理劑所含有之特定聚合物中之四羧酸成分,在不影響本發明之效果的範圍內,也可使用特定四羧酸二酐及特定脂肪族四羧酸二酐以外的四羧酸化合物(也稱為其他的四羧酸化合物)。 The tetracarboxylic acid component in the specific polymer contained in the liquid crystal alignment treatment agent of the present invention may be used in addition to the specific tetracarboxylic dianhydride and the specific aliphatic tetracarboxylic dianhydride insofar as the effects of the present invention are not impaired. Tetracarboxylic acid compounds (also known as other tetracarboxylic acid compounds).

其具體例,例如有以下所示之四羧酸二酐、四羧酸化合物或二羧酸二鹵化物化合物。 Specific examples thereof include a tetracarboxylic dianhydride, a tetracarboxylic acid compound, or a dicarboxylic acid dihalide compound shown below.

可舉出苯均四酸、2,3,6,7-萘四羧酸、1,2,5,6-萘四羧酸、1,4,5,8-萘四羧酸、2,3,6,7-蒽四羧酸、1,2,5,6-蒽四羧酸、3,3’,4,4’-聯苯四羧酸、2,3,3’,4’-聯苯四羧酸、雙(3,4-二羧基苯基)醚、3,3’,4,4’-二苯甲酮四羧酸、雙(3,4-二羧基苯基)碸、雙(3,4-二羧基苯基)甲烷、2,2-雙(3,4-二羧基苯基)丙烷、1,1,1,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二甲基矽烷、雙(3,4-二羧基苯基)二苯基矽烷、2,3,4,5-吡啶四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、3,3’,4,4’-二苯基碸四羧酸、3,4,9,10-苝四羧酸或1,3-二苯基-1,2,3,4-環丁烷四羧酸。 Mention may be made of pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, 1,2,5,6-naphthalenetetracarboxylic acid, 1,4,5,8-naphthalenetetracarboxylic acid, 2,3 6,7-nonanetetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3',4,4'-biphenyltetracarboxylic acid, 2,3,3',4'-linked Pyromellitic acid, bis(3,4-dicarboxyphenyl)ether, 3,3',4,4'-benzophenonetetracarboxylic acid, bis(3,4-dicarboxyphenyl)fluorene, double (3,4-dicarboxyphenyl)methane, 2,2-bis(3,4-dicarboxyphenyl)propane, 1,1,1,3,3,3-hexafluoro-2,2-dual ( 3,4-Dicarboxyphenyl)propane, bis(3,4-dicarboxyphenyl)dimethyloxane, bis(3,4-dicarboxyphenyl)diphenylnonane, 2,3,4,5 -pyridinetetracarboxylic acid, 2,6-bis(3,4-dicarboxyphenyl)pyridine, 3,3',4,4'-diphenylphosphonium tetracarboxylic acid, 3,4,9,10-anthracene Tetracarboxylic acid or 1,3-diphenyl-1,2,3,4-cyclobutanetetracarboxylic acid.

其他的四羧酸化合物,配合本發明之液晶配向處理劑所含有之特定聚合物對溶劑之溶解性或液晶配向處理劑之塗佈性、作為液晶配向膜時之液晶之配向性、電壓保持率、蓄積電荷等的特性,可以1種類或混合2種類以上使用。 The tetracarboxylic acid compound, the solubility of the specific polymer contained in the liquid crystal alignment agent of the present invention, the solubility of the liquid crystal alignment treatment agent, the alignment property of the liquid crystal when the liquid crystal alignment film is used, and the voltage retention ratio The characteristics of accumulating charges and the like can be used in one type or in a mixture of two or more types.

<二胺成分> <Diamine component>

製作本發明之液晶配向處理劑所含有之特定聚合物用的二胺成分,可使用公知之二胺成分。 A known diamine component can be used as the diamine component for the specific polymer contained in the liquid crystal alignment agent of the present invention.

其中使用具有以下述式[3]所示之結構的二胺化合物較佳。 Among them, a diamine compound having a structure represented by the following formula [3] is preferably used.

式[3]中,Y表示選自下述式[3-1]、式[3-2]、式[3-3]、式[3-4]、[3-5]或式[3-6]之至少一個一價基,m表示1~4之整數,-(Y)m表示具有m個取代基Y。 In the formula [3], Y represents a formula selected from the following formula [3-1], formula [3-2], formula [3-3], formula [3-4], [3-5] or formula [3- 6] at least one monovalent group, m represents an integer of 1 to 4, and -(Y) m represents m substituents Y.

式[3-1]中,a表示0~4之整數。其中,就原料之取得性或合成之容易度的觀點,較佳為0或1之整數。 In the formula [3-1], a represents an integer of 0 to 4. Among them, from the viewpoint of availability of raw materials or ease of synthesis, an integer of 0 or 1 is preferred.

式[3-2]中,b表示0~4之整數。其中,就原料之取得性或合成之容易度的觀點,較佳為0或1之整數。 In the formula [3-2], b represents an integer of 0 to 4. Among them, from the viewpoint of availability of raw materials or ease of synthesis, an integer of 0 or 1 is preferred.

式[3-3]中,Y1表示單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中,就原料之取得性或合成之容易度的觀點,較佳為單鍵、-(CH2)a-(a為1~15之整數)、-O-、-CH2O-或-COO-。更佳為單鍵、-(CH2)a-(a為1~10之整數)、-O-、-CH2O-或-COO-。 In the formula [3-3], Y 1 represents a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, from the viewpoint of availability of raw materials or ease of synthesis, a single bond, -(CH 2 ) a - (a is an integer of 1 to 15), -O-, -CH 2 O- or -COO is preferred. -. More preferably a single bond, - (CH 2) a - (a is an integer of 1 to 10), - O -, - CH 2 O- or -COO-.

式[3-3]中,Y2表示單鍵或-(CH2)b-(b為1~15之整數)。其中,較佳為單鍵或-(CH2)b-(b為1~10之整數)。 In the formula [3-3], Y 2 represents a single bond or -(CH 2 ) b - (b is an integer of 1 to 15). Among them, a single bond or -(CH 2 ) b - (b is an integer of 1 to 10) is preferable.

式[3-3]中,Y3表示單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-、-COO-或-OCO-。其中,就合成之容易度的觀點,較佳為單鍵、-(CH2)c-(c為1~15之整數)、-O-、-CH2O-或-COO-。更佳為單鍵、-(CH2)c-(c為1~10之整數)、-O-、-CH2O-或-COO-。 In the formula [3-3], Y 3 represents a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O-, -COO- or -OCO-. Among them, from the viewpoint of easiness of synthesis, a single bond, -(CH 2 ) c - (c is an integer of 1 to 15), -O-, -CH 2 O- or -COO- is preferable. More preferably a single bond, - (CH 2) c - (c is an integer of 1 to 10), - O -, - CH 2 O- or -COO-.

式[3-3]中,Y4為選自苯環、環己烷環或雜環中的二價環狀基,此等環狀基上的任意氫原子可經碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。此外,Y4也可為選自具有類固醇骨架之碳數12~25之有機基的二價有機基。其中,就合成之容易度的觀點,較佳為苯環、環己烷環或具有類固醇骨架之碳數17~51之有機基。 In the formula [3-3], Y 4 is a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, and any hydrogen atom on the cyclic group may pass through an alkyl group having 1 to 3 carbon atoms. The group is substituted with an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Further, Y 4 may also be a divalent organic group selected from an organic group having a carbon number of 12 to 25 having a steroid skeleton. Among them, from the viewpoint of easiness of synthesis, a benzene ring, a cyclohexane ring or an organic group having a carbon number of 17 to 51 having a steroid skeleton is preferred.

式[3-3]中,Y5表示選自苯環、環己烷環或雜環中的二價環狀基,此等環狀基上的任意氫原子可經碳數1~3之烷基、碳數1~3之烷氧基、碳數1~3之含氟烷基、碳數1~3之含氟烷氧基或氟原子所取代。其中,較佳為苯環或環己烷環。 In the formula [3-3], Y 5 represents a divalent cyclic group selected from a benzene ring, a cyclohexane ring or a heterocyclic ring, and any hydrogen atom on the cyclic group may pass through an alkyl group having 1 to 3 carbon atoms. The group is substituted with an alkoxy group having 1 to 3 carbon atoms, a fluorine-containing alkyl group having 1 to 3 carbon atoms, a fluorine-containing alkoxy group having 1 to 3 carbon atoms or a fluorine atom. Among them, a benzene ring or a cyclohexane ring is preferred.

式[3-3]中,n表示0~4之整數。其中,就原料之取得性或合成之容易度的觀點,較佳為0~3之整數。更佳為0~2之整數。 In the formula [3-3], n represents an integer of 0 to 4. Among them, from the viewpoint of availability of raw materials or ease of synthesis, an integer of 0 to 3 is preferable. More preferably, it is an integer of 0~2.

式[3-3]中,Y6表示碳數1~18之烷基、碳數1~18之含氟烷基、碳數1~18之烷氧基或碳數1~18之含氟烷氧基。其中,較佳為碳數1~18之烷基、碳數1~10之含氟烷基、碳數1~18之烷氧基或碳數1~10之含氟烷氧基。更佳為碳數1~12之烷基或碳數1~12之烷氧基。特佳為碳數1~9之烷基或碳數1~9之烷氧基。 In the formula [3-3], Y 6 represents an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 18 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkane having 1 to 18 carbon atoms. Oxygen. Among them, an alkyl group having 1 to 18 carbon atoms, a fluorine-containing alkyl group having 1 to 10 carbon atoms, an alkoxy group having 1 to 18 carbon atoms or a fluorine-containing alkoxy group having 1 to 10 carbon atoms is preferable. More preferably, it is an alkyl group having 1 to 12 carbon atoms or an alkoxy group having 1 to 12 carbon atoms. Particularly preferred are alkyl groups having 1 to 9 carbon atoms or alkoxy groups having 1 to 9 carbon atoms.

構成式[3]中之取代基Y之式[3-3]中之Y1、Y2、Y3、Y4、Y5、Y6及n之較佳的組合,例如有與國際公開公報WO2011/132751之13項~34項之表6~表47中 所揭示的(2-1)~(2-629)相同的組合。此外,在國際公開公報之各表中,雖本發明之Y1~Y6係以Y1~Y6表示,但Y1~Y6也可解讀為Y1~Y6者。具有類固醇骨架之碳數12~25之有機基解讀為具有類固醇骨架之碳數17~51之有機基。 A preferred combination of Y 1 , Y 2 , Y 3 , Y 4 , Y 5 , Y 6 and n in the formula [3-3] of the substituent Y in the formula [3], for example, is related to the international publication. The same combination of (2-1) to (2-629) disclosed in Tables 13 to 47 of 13 to 34 of WO2011/132751. Further, in the tables of the International Publications, although Y 1 to Y 6 of the present invention are represented by Y1 to Y6, Y1 to Y6 can also be interpreted as Y 1 to Y 6 . The organic group having a carbon number of 12 to 25 having a steroid skeleton is interpreted as an organic group having a carbon number of 17 to 51 having a steroid skeleton.

式[3-4]中,Y7表示-O-、-CH2O-、-COO-、-OCO-、-CONH-或-NHCO-。其中較佳為-O-、-CH2O-、-COO-或-CONH-。更佳為-O-、-COO-或-CONH-。 In the formula [3-4], Y 7 represents -O-, -CH 2 O-, -COO-, -OCO-, -CONH- or -NHCO-. Of these, -O-, -CH 2 O-, -COO- or -CONH- are preferred. More preferably -O-, -COO- or -CONH-.

式[3-4]中,Y8表示碳數8~22之烷基。 In the formula [3-4], Y 8 represents an alkyl group having 8 to 22 carbon atoms.

式[3-5]中,Y9及Y10分別獨立表示碳數1~12之烴基。 In the formula [3-5], Y 9 and Y 10 each independently represent a hydrocarbon group having 1 to 12 carbon atoms.

式[3-6]中,Y11表示碳數1~5之烷基。 In the formula [3-6], Y 11 represents an alkyl group having 1 to 5 carbon atoms.

製造前述式[3]所示之二胺化合物的方法,並無特別限定,較佳方法例如有下述所示者。其中一例為式[3]所示的二胺化合物係合成下述式[3-A]所示的二硝基體化合物,接著使該硝基還原並轉換成胺基而得。 The method for producing the diamine compound represented by the above formula [3] is not particularly limited, and preferred methods are, for example, those described below. One of the examples is a diamine compound represented by the formula [3] which is obtained by synthesizing a dinitro compound represented by the following formula [3-A], followed by reduction of the nitro group and conversion into an amine group.

(式[3-A]中,Y表示選自前述式[3-1]、式[3-2]、式[3-3]、式[3-4]、式[3-5]或式[3-6]中之至少1個取代基,m表示1~4之整數)。 (In the formula [3-A], Y represents a formula selected from the above formula [3-1], formula [3-2], formula [3-3], formula [3-4], formula [3-5] or formula At least one substituent in [3-6], m represents an integer of 1 to 4).

使式[3-A]所示之二硝基體化合物之二硝基還 原的方法,無特別限制,一般為於乙酸乙酯、甲苯、四氫呋喃、二噁烷或醇系溶劑等之溶劑中,以鈀-碳、氧化鉑、雷氏鎳、鉑黑、銠-氧化鋁或硫化鉑碳等作為觸媒使用,在氫氣、聯胺或氯化氫下反應的方法。 The dinitro group of the dinitro compound represented by the formula [3-A] is further The original method is not particularly limited, and is generally used in a solvent such as ethyl acetate, toluene, tetrahydrofuran, dioxane or an alcohol solvent, and palladium-carbon, platinum oxide, nickel nickel, platinum black, and rhodium-alumina. Or a method in which platinum sulfide carbon or the like is used as a catalyst and reacted under hydrogen, hydrazine or hydrogen chloride.

下述舉前述式[3]所示的二胺化合物的具體結構,但不限定於此等之例。 The specific structure of the diamine compound represented by the above formula [3] is as follows, but is not limited thereto.

即,式[3]所示之二胺化合物,除了2,4-二甲基-m-苯二胺、2,6-二胺基甲苯、2,4-二胺基苯甲酸、3,5-二胺基苯甲酸、2,4-二胺基酚、3,5-二胺基酚、3,5-二胺基苄醇、2,4-二胺基苄醇、4,6-二胺基間苯二酚外,例如有下述式[3-7]~[3-47]所示之結構的二胺化合物。 That is, the diamine compound represented by the formula [3], except 2,4-dimethyl-m-phenylenediamine, 2,6-diaminotoluene, 2,4-diaminobenzoic acid, 3,5 -diaminobenzoic acid, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-di In addition to the amino resorcin, for example, there are diamine compounds having the structures shown by the following formulas [3-7] to [3-47].

(式[3-7]~式[3-10]中,A1係表示碳數1~22之烷基或含氟烷基)。 (In the formula [3-7] to the formula [3-10], A 1 represents an alkyl group having 1 to 22 carbon atoms or a fluorine-containing alkyl group).

(式[3-35]~式[3-37]中,R1表示-O-、-OCH2-、-CH2O-、 -COOCH2-或CH2OCO-,R2表示碳數1~22之烷基、烷氧基、含氟烷基或含氟烷氧基)。 (In the formula [3-35]~Form [3-37], R 1 represents -O-, -OCH 2 -, -CH 2 O-, -COOCH 2 - or CH 2 OCO-, and R 2 represents a carbon number of 1 ~22 alkyl, alkoxy, fluoroalkyl or fluoroalkoxy).

(式[3-38]~式[3-40]中,R3表示-COO-、-OCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-或-CH2-,R4表示碳數1~22之烷基、烷氧基、含氟烷基或含氟烷氧基)。 (In the formula [3-38]~Form [3-40], R 3 represents -COO-, -OCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 - or - CH 2 -, R 4 represents an alkyl group having 1 to 22 carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a fluorine-containing alkoxy group).

(式[3-41]及式[3-42]中,R5表示-COO-、-OCO-、-COOCH2-、-CH2OCO-、-CH2O-、-OCH2-、-CH2-或-O-,R6表示氟基、氰基、三氟甲烷基、硝基、偶氮基、甲醯基、乙醯基、乙醯氧基或羥基)。 (In the formula [3-41] and the formula [3-42], R 5 represents -COO-, -OCO-, -COOCH 2 -, -CH 2 OCO-, -CH 2 O-, -OCH 2 -, - CH 2 - or -O-, R 6 represents a fluoro group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a decyl group, an ethyl group, an ethoxy group or a hydroxy group).

(式[3-43]及式[3-44]中,R7表示碳數3~12之烷基。此外,1,4-伸環己基之順式-反式異構性係各自為反式異構物較佳)。 (In the formula [3-43] and the formula [3-44], R 7 represents an alkyl group having a carbon number of 3 to 12. Further, the cis-trans isomerization of the 1,4-cyclohexylene group is each a counter Preferred isomers).

(式[3-45]及式[3-46]中,R8表示碳數3~12之烷基。此外,1,4-伸環己基之順式-反式異構性係各自為反式異構物較佳)。 (In the formula [3-45] and the formula [3-46], R 8 represents an alkyl group having 3 to 12 carbon atoms. Further, the cis-trans isomerization of the 1,4-cyclohexylene group is inversely Preferred isomers).

(式[3-47]中,B4表示可經氟原子取代之碳數3~20之烷 基,B3表示1,4-伸環己基或1,4-伸苯基,B2表示氧原子或-COO-*(但是附「*」之鍵結鍵與B3鍵結),B1表示氧原子或-COO-*(但是附「*」之鍵結鍵與(CH2)a2鍵結))。又,a1表示0或1之整數,a2表示2~10之整數,a3表示0或1之整數)。 (In the formula [3-47], B 4 represents an alkyl group having 3 to 20 carbon atoms which may be substituted by a fluorine atom, B 3 represents a 1,4-cyclohexylene group or a 1,4-phenylene group, and B 2 represents an oxygen group. Atom or -COO-* (but with a "*" bond and B 3 bond), B 1 represents an oxygen atom or -COO-* (but with a "*" bond and (CH 2 )a 2 Bond))). Further, a 1 represents an integer of 0 or 1, a 2 represents an integer of 2 to 10, and a 3 represents an integer of 0 or 1.

以前述式[3]表示之二胺化合物中,由使用式[3]中之取代基Y為式[3-3]所示之結構之二胺化合物之特定聚合物所得的液晶配向處理劑,作為液晶配向膜時,可提高液晶的預傾角。此時,以提高此等效果為目的,在上述二胺化合物之中,使用式[3-25]~式[3-40]或式[3-43]~式[3-47]所示的二胺化合物為佳。更佳為式[3-29]~式[3-40]或式[3-43]~式[3-47]所示的二胺化合物。又,為了更提高此等效果,此等二胺化合物較佳為二胺成分整體之5莫耳%以上、80莫耳%以下。從組成物及液晶配向處理劑之塗佈性或作為液晶配向膜之電氣特性的觀點,此等二胺化合物更佳為二胺成分整體的5莫耳%以上、60莫耳%以下。 In the diamine compound represented by the above formula [3], a liquid crystal alignment treatment agent obtained by using a specific polymer of the diamine compound having the structure represented by the formula [3-3] in the formula [3], When it is a liquid crystal alignment film, the pretilt angle of a liquid crystal can be improved. In this case, for the purpose of improving the effects, among the above diamine compounds, the formula [3-25] to the formula [3-40] or the formula [3-43] to the formula [3-47] is used. Diamine compounds are preferred. More preferably, it is a diamine compound represented by the formula [3-29] to the formula [3-40] or the formula [3-43] to the formula [3-47]. Moreover, in order to further enhance these effects, these diamine compounds are preferably 5 mol% or more and 80 mol% or less of the entire diamine component. The diamine compound is more preferably 5 mol% or more and 60 mol% or less of the entire diamine component from the viewpoints of the coating property of the composition and the liquid crystal alignment agent or the electrical properties of the liquid crystal alignment film.

以前述式[3]表示之二胺化合物,配合本發明之液晶配向處理劑所含有之特定聚合物對溶劑之溶解性或塗佈性、作為液晶配向膜時之液晶之配向性、電壓保持率、蓄積電荷等的特性,可以1種類或混合2種類以上使用。 The solubility of the specific polymer contained in the liquid crystal alignment agent of the present invention in the solubility of the diamine compound represented by the above formula [3], or the coating property of the liquid crystal when it is used as a liquid crystal alignment film, and the voltage retention ratio. The characteristics of accumulating charges and the like can be used in one type or in a mixture of two or more types.

製作本發明之液晶配向處理劑所含有之特定聚合物用之二胺成分,可使用以前述式[3]表示之二胺化合物以外的二胺化合物(也稱為其他二胺化合物)。下述 列舉其他二胺化合物,但是不限於此等例。 A diamine compound (also referred to as another diamine compound) other than the diamine compound represented by the above formula [3] can be used as the diamine component for the specific polymer contained in the liquid crystal alignment agent of the present invention. Following Other diamine compounds are listed, but are not limited to these examples.

例如有m-苯二胺、p-苯二胺、4,4’-二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、3,3’-二羥基-4,4’-二胺基聯苯、3,3’-二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-二胺基聯苯、3,3’-三氟甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二苯基甲烷、3,3’-二胺基二苯基甲烷、3,4’-二胺基二苯基甲烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、4,4’-二胺基二苯醚、3,3’-二胺基二苯醚、3,4’-二胺基二苯醚、2,2’-二胺基二苯醚、2,3’-二胺基二苯醚、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二苯胺、3,3’-硫二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、2,3’-二胺基二苯基胺、N-甲基(4,4’-二胺基二苯基)胺、N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二苯基)胺、N-甲基(2,2’-二胺基二苯基)胺、N-甲基(2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5-二胺基萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、1,2-雙(4-胺基苯 基)乙烷、1,2-雙(3-胺基苯基)乙烷、1,3-雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基)苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、4,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,4’-[1,3-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,4-伸苯基雙(亞甲基)]二苯胺、3,3’-[1,3-伸苯基雙(亞甲基)]二苯胺、1,4-伸苯基雙[(4-胺基苯基)甲酮]、1,4-伸苯基雙[(3-胺基苯基)甲酮]、1,3-伸苯基雙[(4-胺基苯基)甲酮]、1,3-伸苯基雙[(3-胺基苯基)甲酮]、1,4-伸苯基雙(4-胺基苯甲酸酯)、1,4-伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙(4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯)、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺基苯基)間苯二甲酸酯、N,N’-(1,4-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(4-胺基苯甲醯胺)、N,N’-(1,4-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-(1,3-伸苯基)雙(3-胺基苯甲醯胺)、N,N’-雙(4-胺基苯基)對苯二甲醯胺、N,N’-雙(3-胺基苯基)對苯二甲醯胺、N,N’-雙(4-胺基苯基)間苯二甲醯胺、 N,N’-雙(3-胺基苯基)間苯二甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺基苯氧基)二苯基碸、2,2’-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氟丙烷、2,2’-雙(3-胺基苯基)六氟丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙(4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、1,3-雙(4-胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷、1,5-雙(3-胺基苯氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧基)庚烷、1,7-(3-胺基苯氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-(4-胺基苯氧基)癸烷、1,10-(3-胺基苯氧基)癸烷、1,11-(4-胺基苯氧基)十一烷、1,11-(3-胺基苯氧基)十一烷、1,12-(4-胺基苯氧基)十二烷、1,12-(3-胺基苯氧基)十二烷、雙(4-胺基環己基)甲烷、雙(4-胺基-3-甲基環己基)甲烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、1,11-二胺基十一烷或1,12-二胺基十二烷等。 For example, there are m-phenylenediamine, p-phenylenediamine, 4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'- Dimethoxy-4,4'-diaminobiphenyl, 3,3'-dihydroxy-4,4'-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diamine Biphenyl, 3,3'-difluoro-4,4'-diaminobiphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-di Aminobiphenyl, 3,3'-diaminobiphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenylmethane , 3,3'-diaminodiphenylmethane, 3,4'-diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenyl Methane, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl ether, 2,2'-diaminodiphenyl ether , 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, bis(4-aminophenyl)decane, double (3- Aminophenyl)decane, dimethyl-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane, 4,4'-thiodiphenylamine, 3,3' -thiodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-di Aminodiphenylamine, 3,4'-diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl (4,4'-Diaminodiphenyl)amine, N-methyl(3,3'-diaminodiphenyl)amine, N-methyl (3,4'-diaminodiphenyl) Amine, N-methyl(2,2'-diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'-diaminodi Benzophenone, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobiphenyl Ketone, 2,3'-diaminobenzophenone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene , 2,5-diaminonaphthalene, 2,6-diaminonaphthalene, 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis(4-aminobenzene) Ethylene, 1,2-bis(3-aminophenyl)ethane, 1,3-bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane , 1,4-bis(4-aminophenyl)butane, 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl) Methane, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1 , 3-bis(4-aminophenyl)benzene, 1,4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'- [1,4-phenylphenylbis(methylene)]diphenylamine, 4,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,4'-[1,4 -phenylphenylbis(methylene)]diphenylamine, 3,4'-[1,3-phenylenebis(methylene)]diphenylamine, 3,3'-[1,4-phenylene Bis(methylene)]diphenylamine, 3,3'-[1,3-phenylenebis(methylene)]diphenylamine, 1,4-phenylene bis[(4-aminophenyl) Methyl ketone], 1,4-phenylene bis[(3-aminophenyl)methanone], 1,3-phenylene bis[(4-aminophenyl)methanone], 1,3- Phenyl bis[(3-aminophenyl)methanone], 1,4-phenylene bis(4-aminobenzoate), 1,4-phenylene bis(3-aminobenzene) Formate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene (3-) Amino benzoate), bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl) Phthalate, bis(3-aminophenyl)isophthalate, N,N'-(1,4-phenylene)bis(4-aminobenzamide), N, N'-(1,3-phenylene) bis(4-aminobenzamide), N,N'-(1,4-phenylene)bis(3-aminobenzamide), N,N'-(1,3-phenylene)bis(3-aminobenzamide), N,N'-bis(4-aminophenyl)terephthalamide, N,N '-bis(3-aminophenyl)terephthalamide, N,N'-bis(4-aminophenyl)m-xylyleneamine, N,N'-bis(3-aminophenyl)m-xylyleneamine, 9,10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxyl) Diphenyl hydrazine, 2,2'-bis[4-(4-aminophenoxy)phenyl]propane, 2,2'-bis[4-(4-aminophenoxy)phenyl] Hexafluoropropane, 2,2'-bis(4-aminophenyl)hexafluoropropane, 2,2'-bis(3-aminophenyl)hexafluoropropane, 2,2'-bis(3-amine 4-methylphenyl)hexafluoropropane, 2,2'-bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'- Bis(3-amino-4-methylphenyl)propane, 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1, 4-bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1 , 5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane, 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminophenoxy)decane 1,10-(4-Aminophenoxy)decane, 1,10-(3-amine Phenoxy)decane, 1,11-(4-aminophenoxy)undecane, 1,11-(3-aminophenoxy)undecane, 1,12-(4-amine Phenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane, bis(4-aminocyclohexyl)methane, bis(4-amino-3-methylcyclohexyl) Methane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoglycol Alkane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,11-diaminoundecane or 1,12-diamine Dodecane and the like.

又,其他二胺化合物例如有在二胺側鏈具有 烷基、含氟烷基、芳香環、脂肪族環或雜環者、及具有由此等所構成之大環狀取代物者等。具體而言,例如有下述式[DA1]~[DA7]所示的二胺化合物。 Further, other diamine compounds have, for example, a side chain in the diamine An alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring or a heterocyclic ring, and a macrocyclic substituent having such a composition. Specifically, for example, there are diamine compounds represented by the following formulas [DA1] to [DA7].

(式[DA1]~式[DA6]中,A1表示-COO-、-OCO-、-CONH-、-NHCO-、-CH2-、-O-、-CO-或-NH-;A2表示碳數1~22之直鏈狀或分支狀之烷基、或碳數1~22之直鏈狀或分支狀之含氟烷基)。 (In the formula [DA1]~Form [DA6], A 1 represents -COO-, -OCO-, -CONH-, -NHCO-, -CH 2 -, -O-, -CO- or -NH-; A 2 It is a linear or branched alkyl group having 1 to 22 carbon atoms or a linear or branched fluorine-containing alkyl group having 1 to 22 carbon atoms.

(式[DA7]中,p表示1~10之整數)。 (In the formula [DA7], p represents an integer from 1 to 10).

在不損及本發明效果的範圍內,其他二胺化合物可使用下述式[DA8]~式[DA13]所示的二胺化合物。 The diamine compound represented by the following formula [DA8] to formula [DA13] can be used as the other diamine compound insofar as the effect of the present invention is not impaired.

(式[DA10]中,m表示0~3之整數,式[DA13]中,n表示1~5之整數)。 (In the formula [DA10], m represents an integer of 0 to 3, and in the formula [DA13], n represents an integer of 1 to 5).

此外,在不損及本發明效果的範圍內,其他二胺化合物也可使用下述式[DA14]~式[DA17]所示的二胺化合物。 In addition, as the other diamine compound, a diamine compound represented by the following formula [DA14] to formula [DA17] can be used as long as the effect of the present invention is not impaired.

(式[DA14]中,A1表示單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,m1及m2各自表示0~4之整數,且m1+m2表示1~4之整數,式[DA15]中,m3及m4各自表示1~5之整數,式[DA16]中,A2表示碳數1~5之直鏈或分支烷基,m5表示1~5之整數,式[DA17]中,A3表示單鍵、-CH2-、-C2H4-、-C(CH3)2-、-CF2-、-C(CF3)2-、-O-、-CO-、-NH-、-N(CH3)-、-CONH-、-NHCO-、-CH2O-、-OCH2-、-COO-、-OCO-、-CON(CH3)-或-N(CH3)CO-,m6表示1~4之整數)。 (In the formula [DA14], A 1 represents a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O -, -CO-, -NH-, -N(CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO-, m 1 and m 2 each represent an integer of 0 to 4, and m 1 + m 2 represents an integer of 1 to 4, and in the formula [DA15], m 3 and m 4 are each An integer representing from 1 to 5, in the formula [DA16], A 2 represents a linear or branched alkyl group having 1 to 5 carbon atoms, m 5 represents an integer of 1 to 5, and in the formula [DA17], A 3 represents a single bond, -CH 2 -, -C 2 H 4 -, -C(CH 3 ) 2 -, -CF 2 -, -C(CF 3 ) 2 -, -O-, -CO-, -NH-, -N ( CH 3 )-, -CONH-, -NHCO-, -CH 2 O-, -OCH 2 -, -COO-, -OCO-, -CON(CH 3 )- or -N(CH 3 )CO-,m 6 represents an integer from 1 to 4).

此外,其他二胺化合物也可使用下述式 [DA18]及式[DA19]表示之二胺化合物。 In addition, other diamine compounds can also use the following formula [DA18] and a diamine compound represented by the formula [DA19].

上述例示之其他二胺化合物,配合本發明之液晶配向處理劑所含有之特定聚合物對溶劑之溶解性或組成物之塗佈性、作為液晶配向膜時之液晶之配向性、電壓保持率、蓄積電荷等的特性,可以1種類或混合2種類以上使用。 The other diamine compound exemplified above, the solubility of the specific polymer contained in the liquid crystal alignment agent of the present invention, the coating property of the solvent, the alignment property of the liquid crystal when the liquid crystal alignment film is used, the voltage retention ratio, The characteristics of the accumulated charges and the like can be used in one type or in a mixture of two or more types.

<特定聚合物> <specific polymer>

本發明之液晶配向處理劑所含有之特定聚合物係選自使含有以前述式[1]表示之特定四羧酸二酐之特定四羧酸成分及含有以前述式[2]表示之特定脂肪族四羧酸二酐的特定脂肪族四羧酸成分與上述二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種的聚合物。 The specific polymer contained in the liquid crystal alignment treatment agent of the present invention is selected from the group consisting of a specific tetracarboxylic acid component containing the specific tetracarboxylic dianhydride represented by the above formula [1] and containing the specific fat represented by the above formula [2]. a polyimine precursor obtained by reacting a specific aliphatic tetracarboxylic acid component of a tetracarboxylic dianhydride with a diamine component, and a polyimine obtained by subjecting the polyimine precursor to ruthenium imidization At least one polymer.

又,前述特定脂肪族四羧酸成分與上述二胺成分進行反應所得之聚醯亞胺前驅物,例如有以下述式[A]表示之結構。 In addition, the polyimine precursor obtained by reacting the specific aliphatic tetracarboxylic acid component with the above-described diamine component has a structure represented by the following formula [A].

(式[A]中,R1係來自特定脂肪族四羧酸成分之4價有機基,R2係來自二胺成分之2價有機基,A1及A2係表示氫原子或碳數1~8之烷基,各自可相同或相異,A3及A4係表示氫原子、碳數1~5之烷基或乙醯基,各自可相同或相異,n表示正整數)。 (In the formula [A], R 1 is a tetravalent organic group derived from a specific aliphatic tetracarboxylic acid component, R 2 is derived from a divalent organic group of a diamine component, and A 1 and A 2 are a hydrogen atom or a carbon number of 1 The alkyl groups of ~8 may be the same or different, and A 3 and A 4 represent a hydrogen atom, an alkyl group having 1 to 5 carbon atoms or an ethyl fluorenyl group, each of which may be the same or different, and n represents a positive integer).

本發明之液晶配向處理劑所含有之特定聚合物,從以前述式[1]表示之特定四羧酸二酐、以下述式[B]表示之特定脂肪族四羧酸二酐及下述式[C]表示之二胺化合物作為原料,而可以簡便製得的理由,因此較佳為由下述式[D]表示之重複單位之結構式所構成之聚醯胺酸或將該聚醯胺酸進行醯亞胺化的聚醯亞胺。又,以式[B]表示之特定四羧酸二酐係與前述式[2]表示之特定脂肪族四羧酸二酐同樣。此時,式[B]中之R1係與式[2]中之Z1相同的4價基。 The specific polymer contained in the liquid crystal alignment agent of the present invention is a specific tetracarboxylic dianhydride represented by the above formula [1], a specific aliphatic tetracarboxylic dianhydride represented by the following formula [B], and the following formula. The reason why the diamine compound represented by [C] is a raw material and can be easily produced is therefore a polylysine which is composed of a structural formula of a repeating unit represented by the following formula [D] or the polyamine. The acid is subjected to a ruthenium imidized polyimine. Further, the specific tetracarboxylic dianhydride represented by the formula [B] is the same as the specific aliphatic tetracarboxylic dianhydride represented by the above formula [2]. At this time, R 1 in the formula [B] is the same tetravalent group as Z 1 in the formula [2].

(式[B]及式[C]中,R1及R2係與式[A]所定義者相同意義)。 (In the formula [B] and the formula [C], R 1 and R 2 have the same meanings as defined in the formula [A]).

(式[D]中,R1及R2係與式[A]所定義者相同意義)。 (In the formula [D], R 1 and R 2 have the same meanings as defined in the formula [A]).

又,以通常的合成手法,可將式[A]表示之A1及A2之碳數1~8之烷基及式[A]表示之A3及A4之碳數1~5之烷基或乙醯基導入於上述所得之式[D]的聚合物中。 Further, an alkyl group having 1 to 8 carbon atoms of A 1 and A 2 represented by the formula [A] and an alkane having 1 to 5 carbon atoms of A 3 and A 4 represented by the formula [A] can be obtained by a usual synthesis method. The group or the ethyl group is introduced into the polymer of the formula [D] obtained above.

<特定聚合物之製造方法> <Method of Manufacturing Specific Polymer>

本發明之特定聚合物係將含有以前述式[1]表示之特定四羧酸二酐及前述式[2]表示之特定脂肪族四羧酸二酐的四羧酸成分與二胺成分進行反應所得。具體而言,可使用使特定四羧酸二酐、特定脂肪族四羧酸二酐及二胺成分進行聚縮合得到聚醯胺酸的方法及使四羧酸成分與二胺成分進行脫水聚縮合或聚縮合得到聚醯胺酸的方法。 The specific polymer of the present invention reacts a tetracarboxylic acid component containing a specific tetracarboxylic dianhydride represented by the above formula [1] and a specific aliphatic tetracarboxylic dianhydride represented by the above formula [2] with a diamine component. Income. Specifically, a method of polycondensing a specific tetracarboxylic dianhydride, a specific aliphatic tetracarboxylic dianhydride, and a diamine component to obtain a polyamic acid, and dehydrating polycondensation of a tetracarboxylic acid component and a diamine component can be used. Or a method of polycondensation to obtain poly-proline.

為了得到聚醯胺酸烷酯時,可使用以下的方 法:使羧酸基進行二烷酯化的四羧酸與二胺成分進行聚縮合的方法及使羧酸基進行二烷酯化之四羧酸二鹵化物與二胺成分進行聚縮合的方法或使聚醯胺酸之羧基轉換成酯的方法。 In order to obtain polyalkyl amide, the following formula can be used. Method for polycondensing a tetracarboxylic acid and a diamine component which dialkylate a carboxylic acid group, and a method for polycondensing a dicarboxylic acid dihalide and a diamine component which dialkylate a carboxylic acid group Or a method of converting a carboxyl group of polyproline to an ester.

為了得到聚醯亞胺,可使用使前述聚醯胺酸或聚醯胺酸烷酯進行閉環,形成聚醯亞胺的方法。 In order to obtain a polyimine, a method of forming a polyimine by ring-closing the polyamic acid or polyalkyl amide may be used.

二胺成分與四羧酸成分之反應,通常使二胺成分與四羧酸成分在有機溶劑中進行。此時所使用的有機溶劑,只要是可溶解生成的聚醯亞胺前驅物者即可,並無特別限定。下述列舉反應用的有機溶劑的具體例,但是不限於此等例。 The reaction of the diamine component with the tetracarboxylic acid component usually involves the diamine component and the tetracarboxylic acid component in an organic solvent. The organic solvent to be used in this case is not particularly limited as long as it is a polyimide precursor which can be produced by dissolution. Specific examples of the organic solvent used for the reaction are listed below, but are not limited to these examples.

例如有N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮或γ-丁內酯、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、二甲基亞碸、1,3-二甲基-咪唑啉酮、甲基乙基酮、環己酮、環戊酮、4-羥基-4-甲基-2-戊酮或下述式[D-1]~式[D-3]表示之溶劑等。 For example, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ-butyrolactone, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl Amidoxime, 1,3-dimethyl-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone, 4-hydroxy-4-methyl-2-pentanone or the following formula [D- 1]~ Solvent represented by the formula [D-3].

(式[D-1]中,D1表示碳數1~3之烷基,於式[D-2]中,D2表示碳數1~3之烷基,於式[D-3]中,D3表示碳數1~4之烷基)。 (In the formula [D-1], D 1 represents an alkyl group having 1 to 3 carbon atoms, and in the formula [D-2], D 2 represents an alkyl group having 1 to 3 carbon atoms, in the formula [D-3] , D 3 represents an alkyl group having 1 to 4 carbon atoms).

此等可單獨使用或混合使用。此外,即使為不會溶解聚醯亞胺前驅物的溶劑,只要是生成後的聚醯亞胺前驅物不會析出的範圍內,也可混合於上述溶劑中使用。又,有機溶劑中之水分會阻礙聚合反應,而且成為使生成後之聚醯亞胺前驅物水解的原因,故有機溶劑較佳為使用已脫水乾燥者。 These can be used alone or in combination. Further, even a solvent which does not dissolve the polyimide precursor can be used in the above solvent as long as it does not precipitate in the precipitated polyimide precursor. Further, since the water in the organic solvent hinders the polymerization reaction and causes hydrolysis of the produced polyimide precursor, the organic solvent is preferably dried and dried.

使二胺成分與四羧酸成分在有機溶劑中反應時,例如:將有機溶劑中分散或溶解有二胺成分之溶液攪拌,使四羧酸成分直接添加,或使四羧酸成分分散或溶解於有機溶劑中添加的方法;相反地,使有機溶劑中分散或溶解有四羧酸成分之溶液中,添加二胺成分的方法;使四羧酸成分與二胺成分交互添加的方法等,可使用此等任一的方法。又,將二胺成分或四羧酸成分以分別使用複數種類來反應時,可以預先經混合的狀態下來進行反應,也可各別依順序來進行反應,此外,也可將已各別反應的低分子量體混合反應使成為聚合物。此時的聚合溫度,可選擇-20℃~150℃的任意溫度,但較佳為-5℃~100℃之範圍。又,反應可以任意濃度來進行,但當濃度過低時,變得難以得到高分子量的聚合物,當濃度過高時,反應液之黏性會變得過高,而難以均勻地攪拌。因此,較佳為1~50質量%,更佳為5~30質量%。反應初期係在高濃度下進行,之後可追加有機溶劑。 When the diamine component and the tetracarboxylic acid component are reacted in an organic solvent, for example, a solution in which a diamine component is dispersed or dissolved in an organic solvent is stirred to directly add a tetracarboxylic acid component or to disperse or dissolve a tetracarboxylic acid component. a method of adding to an organic solvent; conversely, a method of adding a diamine component to a solution in which a tetracarboxylic acid component is dispersed or dissolved in an organic solvent; a method of adding a tetracarboxylic acid component and a diamine component, etc. Use any of these methods. Further, when the diamine component or the tetracarboxylic acid component is reacted in a plurality of types, the reaction may be carried out in a state of being mixed beforehand, or the reaction may be carried out in sequence, or the respective reactions may be carried out. The low molecular weight body is mixed to form a polymer. The polymerization temperature at this time may be any temperature of from -20 ° C to 150 ° C, but is preferably in the range of from -5 ° C to 100 ° C. Further, the reaction can be carried out at any concentration. However, when the concentration is too low, it becomes difficult to obtain a polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction liquid becomes too high, and it is difficult to uniformly stir. Therefore, it is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the reaction is carried out at a high concentration, and then an organic solvent can be added.

在聚醯亞胺前驅物之聚合反應中,二胺成分的合計莫耳數與四羧酸成分之合計莫耳數之比,較佳為 0.8~1.2。與一般的聚縮合反應相同,當此莫耳比越接近1.0時,所生成的聚醯亞胺前驅物之分子量會變得越大。 In the polymerization reaction of the polyimide precursor, the ratio of the total number of moles of the diamine component to the total number of moles of the tetracarboxylic acid component is preferably 0.8~1.2. As with the general polycondensation reaction, as the molar ratio approaches 1.0, the molecular weight of the resulting polyimine precursor becomes larger.

構成本發明之液晶配向處理劑所含有之特定聚合物之聚醯亞胺係使前述聚醯亞胺前驅物閉環而得的聚醯亞胺,此聚醯亞胺中,醯胺酸基之閉環率(也稱為醯亞胺化率)不一定要100%,可因應用途或目的而任意調整。 The polyimine which constitutes a specific polymer contained in the liquid crystal alignment treatment agent of the present invention is a polyimine obtained by ring-closing the polyimine precursor, and a closed loop of a proline group in the polyimide. The rate (also referred to as the oxime imidization rate) does not have to be 100%, and can be arbitrarily adjusted depending on the purpose or purpose.

使聚醯亞胺前驅物進行醯亞胺化的方法,例如有將聚醯亞胺前驅物之溶液直接進行加熱的熱醯亞胺化或將觸媒添加於聚醯亞胺前驅物之溶液中的觸媒醯亞胺化。 A method for subjecting a polyimine precursor to ruthenium imidization, for example, a hydrazine imidization in which a solution of a polyimide precursor is directly heated or a catalyst is added to a solution of a polyimide precursor The catalyst is imidized.

使聚醯亞胺前驅物在溶液中進行熱醯亞胺化時的溫度為100℃~400℃,較佳為120℃~250℃,較佳為將因醯亞胺化反應而生成的水予以一邊排除於系外一邊來進行反應。 The temperature at which the polyimine precursor is thermally imidated in the solution is from 100 ° C to 400 ° C, preferably from 120 ° C to 250 ° C, preferably water produced by the imidization reaction. The reaction was carried out while excluding the outside of the system.

聚醯亞胺前驅物之觸媒醯亞胺化係將鹼性觸媒與酸酐添加於聚醯亞胺前驅物的溶液中,並藉由在-20~250℃,較佳為0~180℃下攪拌來進行。鹼性觸媒的量係醯胺酸基之0.5~30莫耳倍,較佳為2~20莫耳倍;酸酐之量為醯胺酸基之1~50莫耳倍,較佳為3~30莫耳倍。鹼性觸媒例如有吡啶、三乙胺、三甲胺、三丁胺或三辛胺等,其中吡啶由於具有進行反應所需之適度的鹼性,故較佳。酸酐例如有乙酸酐、偏苯三甲酸酐或苯均四酸酐等,其中使用乙酸酐時,由於反應結束後的純化變得容易,故 較佳。藉由觸媒醯亞胺化之醯亞胺化率,可藉由調節觸媒量與反應溫度、反應時間來控制。 The catalyst oxime imidization of the polyimine precursor adds a basic catalyst and an acid anhydride to the solution of the polyimide precursor, and is at -20 to 250 ° C, preferably 0 to 180 ° C. Stir under. The amount of the basic catalyst is 0.5 to 30 moles, preferably 2 to 20 moles, of the prolyl group; the amount of the anhydride is 1 to 50 moles of the amidate group, preferably 3 to 30 moles. The basic catalyst is, for example, pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine. Among them, pyridine is preferred because it has a moderate basicity required for carrying out the reaction. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic anhydride. When acetic anhydride is used, purification after completion of the reaction becomes easy. Preferably. The imidization ratio of the imidization by the catalyst oxime can be controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time.

自聚醯亞胺前驅物或聚醯亞胺之反應溶液回收生成後之聚醯亞胺前驅物或聚醯亞胺時,只要將反應溶液投入溶劑中使其沈澱即可。沈澱所用的溶劑,例如有甲醇、乙醇、異丙醇、丙酮、己烷、丁基賽路蘇、庚烷、甲基乙基酮、甲基異丁基酮、甲苯、苯、水等。投入於溶劑中,使沈澱後的聚合物經過濾回收後,可在常壓或減壓下,以常溫或加熱進行乾燥。又,將沈澱回收的聚合物再溶解於有機溶劑中,再沈澱回收之操作重複2~10次時,可減少聚合物中的雜質。此時的溶劑,例如有醇類、酮類、或烴等,使用選自此等中之3種類以上的溶劑時,由於可更進一步提高純化效率,故較佳。 When the resulting polyimine precursor or polyimine is recovered from the reaction solution of the polyimide precursor or the polyimide, the reaction solution is poured into a solvent to precipitate. The solvent used for the precipitation is, for example, methanol, ethanol, isopropanol, acetone, hexane, butyl sirolimus, heptane, methyl ethyl ketone, methyl isobutyl ketone, toluene, benzene, water or the like. After being introduced into a solvent and allowing the precipitated polymer to be recovered by filtration, it can be dried at normal temperature or under reduced pressure under normal pressure or reduced pressure. Further, the precipitate-recovered polymer is redissolved in an organic solvent, and the reprecipitation recovery operation is repeated 2 to 10 times to reduce impurities in the polymer. In the solvent at the time, for example, an alcohol, a ketone, a hydrocarbon, or the like is used, and when a solvent selected from three or more types selected from the above is used, the purification efficiency can be further improved, which is preferable.

本發明之液晶配向處理劑所含有之特定聚合物之分子量,若考慮由此等所得之液晶配向膜之強度、膜形成時之作業性及塗膜性時,以GPC(Gel Permeation Chromatography)法測定之重量平均分子量,較佳為5,000~1,000,000,更佳為10,000~150,000。 The molecular weight of the specific polymer contained in the liquid crystal alignment agent of the present invention is determined by GPC (Gel Permeation Chromatography) method in consideration of the strength of the liquid crystal alignment film obtained by the above, the workability at the time of film formation, and the coating property. The weight average molecular weight is preferably 5,000 to 1,000,000, more preferably 10,000 to 150,000.

<液晶配向處理劑> <Liquid alignment treatment agent>

本發明之液晶配向處理劑係形成液晶配向膜用的塗佈溶液,且含有聚合物成分及溶劑,形成聚合物被膜用的塗佈溶液。 The liquid crystal alignment treatment agent of the present invention forms a coating solution for a liquid crystal alignment film, and contains a polymer component and a solvent to form a coating solution for a polymer film.

如上述,本發明之液晶配向處理劑係含有上 述特定聚合物作為聚合物成分,即選自使含有以上述式[1]表示之特定四羧酸二酐與上述式[2]表示之特定脂肪族四羧酸二酐的四羧酸成分(特定四羧酸成分及特定脂肪族四羧酸成分)與二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種聚合物者。藉由使用含有這種特定聚合物的液晶配向處理劑,可得到光耐性優異、電壓保持特性(電壓保持率)優異的液晶配向膜。關於此理由如以下說明。 As described above, the liquid crystal alignment treatment agent of the present invention contains The specific polymer is selected from the group consisting of a tetracarboxylic acid component containing a specific tetracarboxylic dianhydride represented by the above formula [1] and a specific aliphatic tetracarboxylic dianhydride represented by the above formula [2]. a polyimine precursor obtained by reacting a specific tetracarboxylic acid component and a specific aliphatic tetracarboxylic acid component with a diamine component, and at least a polyimine obtained by subjecting the polyimine precursor to ruthenium imidization 1 kind of polymer. By using a liquid crystal alignment treatment agent containing such a specific polymer, a liquid crystal alignment film excellent in light resistance and excellent in voltage retention characteristics (voltage holding ratio) can be obtained. The reason for this is as follows.

特定四羧酸二酐具有2個二羧酸二酐以亞甲基進行鍵結的結構。亞甲基因可撓性(柔軟),故使具有這種亞甲基之特定四羧酸二酐與特定脂肪族四羧酸二酐與二胺成分進行反應所得之聚醯亞胺前驅物或聚醯亞胺係藉由亞甲基之柔軟性,在分子間內及分子內擬似交聯者。結果,特定聚合物係高分子化,且密度變高。具有密度高之特定聚合物的液晶配向膜,變成緻密的膜,如後述實施例所示,即使強紫外線照射後,也可抑制電壓保持率之降低,成為光耐性優異者。 The specific tetracarboxylic dianhydride has a structure in which two dicarboxylic dianhydrides are bonded by a methylene group. Since the methylene group is flexible (soft), the polytetraimide precursor or polycondensation obtained by reacting the specific tetracarboxylic dianhydride having such a methylene group with a specific aliphatic tetracarboxylic dianhydride and a diamine component The quinone imine is a cross-linker in the molecule and in the molecule by the softness of the methylene group. As a result, the specific polymer is polymerized and the density is high. The liquid crystal alignment film having a specific polymer having a high density becomes a dense film, and as shown in the examples below, even after strong ultraviolet irradiation, the voltage holding ratio can be suppressed from being lowered, and the light resistance is excellent.

一般而言,芳香族酸酐係光耐性較弱者,但是特定四羧酸二酐係具有如上述柔軟的亞甲基,故具有特定聚合物之液晶配向膜的光耐性不會降低,可維持高的電壓保持率。 In general, the aromatic acid anhydride is weak in light resistance, but the specific tetracarboxylic dianhydride has a soft methylene group as described above, so that the light resistance of the liquid crystal alignment film having a specific polymer does not decrease and can be maintained high. Voltage retention rate.

這種優異的電壓保持特性係因使用具有亞甲基之特定四羧酸二酐與非芳香族之特定脂肪族四羧酸二酐作為特定聚合物的原料,因此可進一步增加效果。 Such excellent voltage holding characteristics are obtained by using a specific tetracarboxylic dianhydride having a methylene group and a non-aromatic specific aliphatic tetracarboxylic dianhydride as a raw material of a specific polymer, so that the effect can be further increased.

以上的結果,藉由使用特定四羧酸二酐及特定脂肪族四羧酸二酐之2種類的四羧酸二酐,作為本發明之液晶配向處理劑所含有之特定聚合物的原料,可得到光耐性優異、電壓保持特性優異的液晶配向膜。 As a result of the above, by using two kinds of tetracarboxylic dianhydrides of a specific tetracarboxylic dianhydride and a specific aliphatic tetracarboxylic dianhydride, it can be used as a raw material of the specific polymer contained in the liquid crystal alignment treatment agent of the present invention. A liquid crystal alignment film which is excellent in light resistance and excellent in voltage retention characteristics is obtained.

本發明之液晶配向處理劑中之全部的聚合物成分可全部為特定聚合物,也可混該聚合物以外的其他聚合物。此時,該聚合物以外之其他聚合物的含量為特定聚合物之0.5質量%~15質量%,較佳為1質量%~10質量%。該聚合物以外之其他聚合物,例如有未使用以前述式[1]表示之特定四羧酸二酐及前述式[2]表示之特定脂肪族四羧酸二酐的聚醯亞胺前驅物或聚醯亞胺。此外,例如有丙烯酸聚合物、甲基丙烯酸聚合物、聚苯乙烯或聚矽氧烷等。 All of the polymer components in the liquid crystal alignment treatment agent of the present invention may be all specific polymers, or may be mixed with other polymers other than the polymer. In this case, the content of the polymer other than the polymer is 0.5% by mass to 15% by mass, preferably 1% by mass to 10% by mass based on the specific polymer. Other polymers other than the polymer include, for example, a polyimine precursor which does not use the specific tetracarboxylic dianhydride represented by the above formula [1] and the specific aliphatic tetracarboxylic dianhydride represented by the above formula [2]. Or polyimine. Further, there are, for example, an acrylic polymer, a methacrylic polymer, polystyrene or polyoxyalkylene.

本發明之液晶配向處理劑中之固形分濃度,可藉由設定形成之液晶配向膜的厚度,適當變更,較佳為0.5~10質量%,更佳為1~8質量%。固形分濃度未達0.5質量%時,有時形成均勻且無缺陷之塗膜變得困難,而多於10質量%時,有時溶液之保存安定性變差。在此所謂的固形分係指由液晶配向處理劑中除去溶劑後的成分,係指上述特定聚合物、該聚合物以外的其他聚合物、後述各種的添加劑。 The solid content concentration in the liquid crystal alignment agent of the present invention can be appropriately changed by setting the thickness of the liquid crystal alignment film to be formed, and is preferably 0.5 to 10% by mass, and more preferably 1 to 8% by mass. When the solid content concentration is less than 0.5% by mass, it may become difficult to form a uniform and non-defective coating film, and when it is more than 10% by mass, the storage stability of the solution may be deteriorated. Here, the solid component refers to a component obtained by removing a solvent from a liquid crystal alignment treatment agent, and refers to the specific polymer described above, a polymer other than the polymer, and various additives described below.

本發明之液晶配向處理劑中之溶劑,就藉由塗佈形成均勻液晶配向膜的觀點,液晶配向處理劑中之溶劑的含量較佳為70~99.9質量%。此含量可依據目的之液 晶配向膜之膜厚而予以適當變更。 The solvent in the liquid crystal alignment treatment agent of the present invention is preferably from 70 to 99.9% by mass in terms of the solvent in the liquid crystal alignment treatment agent from the viewpoint of coating to form a uniform liquid crystal alignment film. This content can be based on the purpose of the liquid The thickness of the crystal alignment film is appropriately changed.

本發明之液晶配向處理劑所使用之溶劑,只要是溶解特定聚合物之溶劑(也稱良溶劑)時,即無特別限定。下述列舉良溶劑的具體例,但是不限於此等例。 The solvent used for the liquid crystal alignment treatment agent of the present invention is not particularly limited as long as it is a solvent (also referred to as a good solvent) for dissolving a specific polymer. Specific examples of the good solvent are listed below, but are not limited to these examples.

例如有N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、二甲基亞碸、γ-丁內酯、1,3-二甲基-咪唑啉酮、甲基乙基酮、環己酮、環戊酮或4-羥基-4-甲基-2-戊酮等。其中較佳為例如N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯或上述式[D-1]~式[D-3]表示之溶劑等。此等可單獨使用或混合使用。 For example, there are N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, dimethyl hydrazine, γ- Butyrolactone, 1,3-dimethyl-imidazolidinone, methyl ethyl ketone, cyclohexanone, cyclopentanone or 4-hydroxy-4-methyl-2-pentanone. Among them, preferred are, for example, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, γ -butyrolactone or a solvent represented by the above formula [D-1] to formula [D-3]. These can be used alone or in combination.

其中較佳為使用N-甲基-2-吡咯烷酮、N-乙基-2-吡咯烷酮、γ-丁內酯。此外,特定聚合物對溶劑之溶解性較高時,較佳為使用以前述式[D-1]~式[D-3]所示之溶劑。 Among them, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, and γ -butyrolactone are preferably used. Further, when the solubility of the specific polymer in the solvent is high, it is preferred to use a solvent represented by the above formula [D-1] to formula [D-3].

本發明之液晶配向處理劑中之良溶劑,較佳為液晶配向處理劑所含有之溶劑整體之10~100質量%。較佳為20~90質量%。更佳為30~80質量%。 The good solvent in the liquid crystal alignment treatment agent of the present invention is preferably from 10 to 100% by mass based on the total amount of the solvent contained in the liquid crystal alignment treatment agent. It is preferably 20 to 90% by mass. More preferably 30 to 80% by mass.

本發明之液晶配向處理劑在不損及本發明之效果的範圍內,可使用提高塗佈液晶配向處理劑時之液晶配向膜之塗膜性或表面平滑性的溶劑(也稱為弱溶劑)。下述列舉弱溶劑之具體例,但是不限於此等例。 The liquid crystal alignment treatment agent of the present invention can use a solvent (also referred to as a weak solvent) for improving the coating property or surface smoothness of the liquid crystal alignment film when the liquid crystal alignment treatment agent is applied, within a range that does not impair the effects of the present invention. . Specific examples of the weak solvent are listed below, but are not limited to these examples.

例如有乙醇、異丙醇、1-丁醇、2-丁醇、異丁醇、tert-丁醇、1-戊醇、2-戊醇、3-戊醇、2-甲基-1-丁 醇、異戊醇、tert-戊醇、3-甲基-2-丁醇、新戊醇、1-己醇、2-甲基-1-戊醇、2-甲基-2-戊醇、2-乙基-1-丁醇、1-庚醇、2-庚醇、3-庚醇、1-辛醇、2-辛醇、2-乙基-1-己醇、環己醇、1-甲基環己醇、2-甲基環己醇、3-甲基環己醇、1,2-乙二醇、1,2-丙二醇、1,3-丙二醇、1,2-丁二醇、1,3-丁二醇、1,4-丁二醇、2,3-丁二醇、1,5-戊二醇、2-甲基-2,4-戊二醇、2-乙基-1,3-己二醇、二丙醚、二丁醚、二己醚、二噁烷、乙二醇二甲醚、乙二醇二乙醚、乙二醇二丁醚、1,2-丁氧基乙烷、二乙二醇二甲醚、二乙二醇二乙醚、二乙二醇甲基乙醚、二乙二醇二丁醚、2-戊酮、3-戊酮、2-己酮、2-庚酮、4-庚酮、3-乙氧基丁基乙酸酯、1-甲基戊基乙酸酯、2-乙基丁基乙酸酯、2-乙基己基乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、碳酸丙烯酯(Propylene carbonate)、碳酸乙烯酯、2-(甲氧基甲氧基)乙醇、乙二醇單丁醚、乙二醇單異戊醚、乙二醇單己醚、2-(己基氧基)乙醇、糠醇、二乙二醇、丙二醇、丙二醇單丁醚、1-(丁氧基乙氧基)丙醇、丙二醇單甲醚乙酸酯、二丙二醇、二丙二醇單甲醚、二丙二醇單乙醚、三丙二醇單甲醚、乙二醇單甲醚乙酸酯、乙二醇單乙醚乙酸酯、乙二醇單丁醚乙酸酯、乙二醇單乙酸酯、乙二醇二乙酸酯、二乙二醇單乙醚乙酸酯、二乙二醇單丁醚乙酸酯、2-(2-乙氧基乙氧基)乙基乙酸酯、二乙二醇乙酸酯、三乙二醇、三乙二醇單甲醚、三乙二醇單乙醚、乳酸甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸n-丁酯、乙酸丙二 醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3-甲氧基丙酸甲酯、3-乙氧基丙酸甲基乙酯、3-甲氧基丙酸乙酯、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、乳酸甲酯、乳酸乙酯、乳酸n-丙酯、乳酸n-丁酯、乳酸異戊酯或前述式[D-1]~式[D-3]表示之溶劑等。 For example, there are ethanol, isopropanol, 1-butanol, 2-butanol, isobutanol, tert-butanol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butene Alcohol, isoamyl alcohol, tert-pentanol, 3-methyl-2-butanol, neopentyl alcohol, 1-hexanol, 2-methyl-1-pentanol, 2-methyl-2-pentanol, 2-ethyl-1-butanol, 1-heptanol, 2-heptanol, 3-heptanol, 1-octanol, 2-octanol, 2-ethyl-1-hexanol, cyclohexanol, 1 -methylcyclohexanol, 2-methylcyclohexanol, 3-methylcyclohexanol, 1,2-ethanediol, 1,2-propanediol, 1,3-propanediol, 1,2-butanediol , 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, 1,5-pentanediol, 2-methyl-2,4-pentanediol, 2-ethyl -1,3-hexanediol, dipropyl ether, dibutyl ether, dihexyl ether, dioxane, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, ethylene glycol dibutyl ether, 1,2-butyl Oxyethane, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol methyl ether, diethylene glycol dibutyl ether, 2-pentanone, 3-pentanone, 2-hexanone , 2-heptanone, 4-heptanone, 3-ethoxybutyl acetate, 1-methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate , ethylene glycol monoacetate, ethylene glycol diacetate, Propylene carbonate, ethylene carbonate, 2-(methoxymethoxy)ethanol, ethylene glycol Butyl ether, ethylene glycol monoisoamyl ether, ethylene glycol monohexyl ether, 2-(hexyloxy)ethanol, decyl alcohol, diethylene glycol, propylene glycol, propylene glycol monobutyl ether, 1-(butoxyethoxy Propyl alcohol, propylene glycol monomethyl ether acetate, dipropylene glycol, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, tripropylene glycol monomethyl ether, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate , ethylene glycol monobutyl ether acetate, ethylene glycol monoacetate, ethylene glycol diacetate, diethylene glycol monoethyl ether acetate, diethylene glycol monobutyl ether acetate, 2- (2-ethoxyethoxy)ethyl acetate, diethylene glycol acetate, triethylene glycol, triethylene glycol monomethyl ether, triethylene glycol monoethyl ether, methyl lactate, lactate B Ester, methyl acetate, ethyl acetate, n-butyl acetate, acrylic acid Alcohol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, ethyl 3-methoxypropionate, 3-ethoxy Propionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate An ester, isoamyl lactate or a solvent represented by the above formula [D-1] to formula [D-3].

其中,較佳為使用1-己醇、環己醇、1,2-乙二醇、1,2-丙二醇、丙二醇單丁醚或乙二醇單丁醚、或前述式[D-1]~式[D-3]表示之溶劑等。 Among them, 1-hexanol, cyclohexanol, 1,2-ethanediol, 1,2-propanediol, propylene glycol monobutyl ether or ethylene glycol monobutyl ether, or the above formula [D-1]~ is preferably used. A solvent or the like represented by the formula [D-3].

此等弱溶劑較佳為液晶配向處理劑中所包含之溶劑整體的1~70質量%。其中,較佳為1~60質量%。更佳為5~60質量%。 These weak solvents are preferably from 1 to 70% by mass based on the total amount of the solvent contained in the liquid crystal alignment agent. Among them, it is preferably from 1 to 60% by mass. More preferably, it is 5 to 60% by mass.

本發明之液晶配向處理劑中,在不損及本發明效果的範圍內,也可含有具有環氧基、異氰酸酯基、氧雜環丁烷(oxetane)基或環狀碳酸酯基之交聯性化合物;具有選自由羥基、羥基烷基及低階烷氧基(lower alkoxy)烷基所成群中至少1種取代基的交聯性化合物;或具有聚合性不飽和鍵之交聯性化合物。此等取代基或聚合性不飽和鍵,在交聯性化合物中必須具有2個以上。 The liquid crystal alignment treatment agent of the present invention may contain crosslinkability having an epoxy group, an isocyanate group, an oxetane group or a cyclic carbonate group, within a range not impairing the effects of the present invention. a compound; a crosslinkable compound having at least one substituent selected from the group consisting of a hydroxyl group, a hydroxyalkyl group, and a lower alkoxy alkyl group; or a crosslinkable compound having a polymerizable unsaturated bond. These substituents or polymerizable unsaturated bonds must have two or more of the crosslinkable compounds.

具有環氧基或異氰酸酯基之交聯性化合物,例如有雙酚丙酮縮水甘油醚、酚醛環氧樹脂、甲酚酚醛環氧樹脂、三縮水甘油基異氰脲酸酯、四縮水甘油基胺基二亞苯(diphenylene)、四縮水甘油基-m-二甲苯二胺、四縮水甘油基-1,3-雙(胺基乙基)環己烷、四苯基縮水甘油醚乙烷、三苯基縮水甘油醚乙烷、雙酚六氟乙醯二縮水甘 油醚、1,3-雙(1-(2,3-環氧丙氧基)-1-三氟甲基-2,2,2-三氟甲基)苯、4,4-雙(2,3-環氧丙氧基)八氟聯苯(Octafluorobiphenyl)、三縮水甘油基-p-胺基酚、四縮水甘油基間二甲苯二胺(meta-xylenediamine)、2-(4-(2,3-環氧丙氧基)苯基)-2-(4-(1,1-雙(4-(2,3-環氧丙氧基)苯基)乙基)苯基)丙烷或1,3-雙(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-(4-(1-(4-(2,3-環氧丙氧基)苯基)-1-甲基乙基)苯基)乙基)苯氧基)-2-丙醇等。 A crosslinkable compound having an epoxy group or an isocyanate group, for example, bisphenol acetone glycidyl ether, novolac epoxy resin, cresol novolac epoxy resin, triglycidyl isocyanurate, tetraglycidylamino group Diphenylene, tetraglycidyl-m-xylylenediamine, tetraglycidyl-1,3-bis(aminoethyl)cyclohexane, tetraphenyl glycidyl ether ethane, triphenyl Glycidyl ether ethane, bisphenol hexafluoroacetamidine dihydrate Oleic ether, 1,3-bis(1-(2,3-epoxypropoxy)-1-trifluoromethyl-2,2,2-trifluoromethyl)benzene, 4,4-bis (2) , 3-glycidoxy) Octafluorobiphenyl, triglycidyl-p-aminophenol, meta-xylenediamine, 2-(4-(2) ,3-glycidoxy)phenyl)-2-(4-(1,1-bis(4-(2,3-epoxypropoxy)phenyl)ethyl)phenyl)propane or 1 ,3-bis(4-(1-(4-(2,3-epoxypropoxy)phenyl)-1-(4-(1-(4-(2,3-epoxypropoxy))) Phenyl)-1-methylethyl)phenyl)ethyl)phenoxy)-2-propanol and the like.

具有氧雜環丁烷基之交聯性化合物係具有至少2個下述式[4]所示之氧雜環丁烷基的交聯性化合物。 The crosslinkable compound having an oxetanyl group is a crosslinkable compound having at least two oxetanyl groups represented by the following formula [4].

具體而言,例如有國際公開公報WO2011/132751之58項~59項所揭示之式[4a]~式[4k]表示之交聯性化合物。 Specifically, for example, there is a crosslinkable compound represented by the formula [4a] to the formula [4k] disclosed in 58-59 of International Publication WO01/132751.

具有環碳酸酯基之交聯性化合物,例如有具有至少2個如下述式[5]所示之環碳酸酯基的交聯性化合物。 The crosslinkable compound having a cyclic carbonate group is, for example, a crosslinkable compound having at least two cyclic carbonate groups represented by the following formula [5].

具體而言,例如有國際公開公報WO2011/132751之76項~82項所揭示之式[5-1]~式[5-42]表示之交聯性化合物。 Specifically, for example, there is a crosslinkable compound represented by the formula [5-1] to the formula [5-42] disclosed in 76-82 of International Publication WO01/132751.

具有選自由羥基及烷氧基所成群中之至少1種取代基的交聯性化合物,例如具有羥基或烷氧基之胺基樹脂,例如有三聚氰胺樹脂、脲樹脂、胍胺(guanamine)樹脂、甘脲(Glycoluril)-甲醛樹脂、丁二醯胺(Succinylamide)-甲醛樹脂或乙烯脲-甲醛樹脂等。具體而言,可使用胺基之氫原子經羥甲基或烷氧基甲基或其兩者所取代的三聚氰胺衍生物、苯胍胺(benzoguanamine)衍生物、或甘脲。此三聚氰胺衍生物或苯胍胺衍生物,可以二聚物或三聚物形式存在。此等係1個三嗪環中,具有平均3個以上且6個以下的羥甲基或烷氧基甲基者較佳。 a crosslinkable compound having at least one substituent selected from the group consisting of a hydroxyl group and an alkoxy group, for example, an amine-based resin having a hydroxyl group or an alkoxy group, for example, a melamine resin, a urea resin, or a guanamine resin , Glycoluril-formaldehyde resin, Succinylamide-formaldehyde resin or ethylene urea-formaldehyde resin. Specifically, a melamine derivative, a benzoguanamine derivative, or a glycoluril in which a hydrogen atom of an amine group is substituted with a methylol group or an alkoxymethyl group or both may be used. The melamine derivative or the benzoguanamine derivative may be present in the form of a dimer or a trimer. Among these, one triazine ring is preferred to have an average of three or more and six or less hydroxymethyl groups or alkoxymethyl groups.

這種三聚氰胺衍生物或苯胍胺衍生物之例,例如市售品之1個三嗪環,經平均3.7個甲氧基甲基所取代的MX-750、1個三嗪環,經平均5.8個甲氧基甲基取代的MW-30(以上為Sanwa-Chemical公司製)或Cymel 300、301、303、350、370、771、325、327、703、712等之甲氧基甲基化三聚氰胺、Cymel 235、236、238、212、253、254等之甲氧基甲基化丁氧基甲基化三聚氰胺、Cymel 506、508等之丁氧基甲基化三聚氰胺、如Cymel 1141之含羧基的甲氧基甲基化異丁氧基甲基化三聚氰胺、如Cymel 1123之甲氧基甲基化乙氧基甲基化苯胍胺、如Cymel 1123-10之甲氧基甲基化丁氧基甲基化苯胍 胺、如Cymel 1128之丁氧基甲基化苯胍胺、如Cymel 1125-80之含羧基的甲氧基甲基化乙氧基甲基化苯胍胺(以上為三井Cyanamid公司製)。又,甘脲例,例如Cymel 1170之丁氧基甲基化甘脲、Cymel 1172之羥甲基化甘脲等、Powderlink 1174之甲氧基羥甲基化甘脲等。 Examples of such a melamine derivative or a benzoguanamine derivative, for example, a triazine ring of a commercial product, MX-750 substituted by an average of 3.7 methoxymethyl groups, and a triazine ring, an average of 5.8. Methoxymethylated melamine substituted by methoxymethyl substituted MW-30 (above manufactured by Sanwa-Chemical Co., Ltd.) or Cymel 300, 301, 303, 350, 370, 771, 325, 327, 703, 712, etc. , methoxymethylated butoxymethylated melamine of Cymel 235, 236, 238, 212, 253, 254, etc., butoxymethylated melamine of Cymel 506, 508, etc., such as carboxyl group of Cymel 1141 Methoxymethylated isobutoxymethylated melamine, such as methoxymethylated ethoxymethylbenzamide of Cymel 1123, methoxymethylated butoxy of Cymel 1123-10 Methylated benzoquinone An amine such as butoxymethyl benzoguanamine of Cymel 1128, a carboxyl group-containing methoxymethylated ethoxymethyl benzoguanamine such as Cymel 1125-80 (manufactured by Mitsui Cyanamid Co., Ltd.). Further, examples of the glycoluril include, for example, butoxymethylated glycoluril of Cymel 1170, methylolated glycoluril of Cymel 1172, and methoxymethylolated glycoluril of Powderlink 1174.

具有羥基或烷氧基之苯或酚性化合物,例如有1,3,5-參(甲氧基甲基)苯、1,2,4-參(異丙氧基甲基)苯、1,4-雙(sec-丁氧基甲基)苯或2,6-二羥基甲基-p-tert-丁基酚等。 a benzene or a phenolic compound having a hydroxyl group or an alkoxy group, for example, 1,3,5-glycol (methoxymethyl)benzene, 1,2,4-para(isopropoxymethyl)benzene, 1, 4-bis(sec-butoxymethyl)benzene or 2,6-dihydroxymethyl-p-tert-butylphenol.

更具體而言,例如國際公開公報WO2011/132751之62頁~66頁中所揭載的式[6-1]~式[6-48]所示的交聯性化合物。 More specifically, for example, the crosslinkable compound represented by the formula [6-1] to the formula [6-48] disclosed in pages 62 to 66 of International Publication WO2011/132751.

具有聚合性不飽和鍵結之交聯性化合物,例如有三羥甲基丙烷三(甲基)丙烯酸酯、季戊四醇三(甲基)丙烯酸酯、二季戊四醇五(甲基)丙烯酸酯、三(甲基)丙烯醯氧基乙氧基三羥甲基丙烷或甘油聚縮水甘油醚聚(甲基)丙烯酸酯等於分子內具有3個聚合性不飽和基之交聯性化合物;此外,例如乙二醇二(甲基)丙烯酸酯、二乙二醇二(甲基)丙烯酸酯、四乙二醇二(甲基)丙烯酸酯、聚乙二醇二(甲基)丙烯酸酯、丙二醇二(甲基)丙烯酸酯、聚丙二醇二(甲基)丙烯酸酯、丁二醇二(甲基)丙烯酸酯、新戊二醇(Neopentyl glycol)二(甲基)丙烯酸酯、環氧乙烷雙酚A型二(甲基)丙烯酸酯、環氧丙烷雙酚型二(甲基)丙烯酸酯、1,6-己二醇二(甲 基)丙烯酸酯、甘油二(甲基)丙烯酸酯、季戊四醇二(甲基)丙烯酸酯、乙二醇二縮水甘油醚二(甲基)丙烯酸酯、二乙二醇二縮水甘油醚二(甲基)丙烯酸酯、酞酸二縮水甘油基酯二(甲基)丙烯酸酯或羥基三甲基乙酸新戊二醇二(甲基)丙烯酸酯等於分子內具有2個聚合性不飽和基之交聯性化合物;此外,例如有2-羥基乙基(甲基)丙烯酸酯、2-羥基丙基(甲基)丙烯酸酯、2-羥基丁基(甲基)丙烯酸酯、2-苯氧基-2-羥基丙基(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基-2-羥基丙基酞酸酯、3-氯-2-羥基丙基(甲基)丙烯酸酯、甘油單(甲基)丙烯酸酯、2-(甲基)丙烯醯氧基乙基磷酸酯或N-羥甲基(甲基)丙烯醯胺等於分子內具有1個聚合性不飽和基之交聯性化合物。 A crosslinkable compound having a polymerizable unsaturated bond, for example, trimethylolpropane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, dipentaerythritol penta(meth)acrylate, tris(methyl) a propylene methoxy ethoxy trimethylolpropane or a glycerol polyglycidyl ether poly(meth) acrylate equivalent to a crosslinkable compound having three polymerizable unsaturated groups in the molecule; further, for example, ethylene glycol (Meth) acrylate, diethylene glycol di(meth) acrylate, tetraethylene glycol di(meth) acrylate, polyethylene glycol di(meth) acrylate, propylene glycol di(meth) acrylate Ester, polypropylene glycol di(meth)acrylate, butanediol di(meth)acrylate, neopentyl glycol di(meth)acrylate, ethylene oxide bisphenol A type II Acrylate, propylene oxide bisphenol type di(meth) acrylate, 1,6-hexanediol di(A) Acrylate, glycerol di(meth)acrylate, pentaerythritol di(meth)acrylate, ethylene glycol diglycidyl ether di(meth)acrylate, diethylene glycol diglycidyl ether di(methyl) Acrylate, bis-glycidyl phthalate di(meth) acrylate or hydroxytrimethyl acetic acid neopentyl glycol di(meth) acrylate is equal to crosslinkability of two polymerizable unsaturated groups in the molecule a compound; further, for example, 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, 2-hydroxybutyl (meth) acrylate, 2-phenoxy-2- Hydroxypropyl (meth) acrylate, 2-(methyl) propylene oxy-2-hydroxypropyl phthalate, 3-chloro-2-hydroxypropyl (meth) acrylate, glycerol mono The acrylate, 2-(meth) propylene methoxyethyl phosphate or N- hydroxymethyl (meth) acrylamide is equivalent to a crosslinkable compound having one polymerizable unsaturated group in the molecule.

此外,也可使用下述式[7]所示的化合物。 Further, a compound represented by the following formula [7] can also be used.

(式[7]中,E1表示選自由環己烷環、雙環己烷環、苯環、聯苯環、聯三苯環、萘環、茀環、蒽環或菲環所成群之基團,E2表示選自下述式[7a]或式[7b]之基團,n表示1~4之整數)。 (In the formula [7], E 1 represents a group selected from the group consisting of a cyclohexane ring, a bicyclohexane ring, a benzene ring, a biphenyl ring, a terphenyl ring, a naphthalene ring, an anthracene ring, an anthracene ring or a phenanthrene ring. The group, E 2 represents a group selected from the following formula [7a] or formula [7b], and n represents an integer of 1 to 4).

上述化合物為交聯性化合物之一例,但不限定於此等。又,本發明之液晶配向處理劑所使用的交聯性化合物,可為1種類或組合2種類以上。 The above compound is an example of a crosslinkable compound, but is not limited thereto. Moreover, the crosslinkable compound used for the liquid crystal alignment treatment agent of the present invention may be one type or a combination of two or more types.

本發明之液晶配向處理劑中之交聯性化合物的含量係相對於全部聚合物成分100質量份,較佳為0.1~150質量份。為了進行交聯反應,展現目的效果時,相對於全部聚合物成分100質量份,更佳為0.1~100質量份,特佳為1~50質量份。 The content of the crosslinkable compound in the liquid crystal alignment agent of the present invention is preferably 0.1 to 150 parts by mass based on 100 parts by mass of the total polymer component. In order to carry out the crosslinking reaction, the effect of the object is preferably from 0.1 to 100 parts by mass, particularly preferably from 1 to 50 parts by mass, per 100 parts by mass of the total polymer component.

使用本發明之組成物的液晶配向處理劑作為液晶配向膜時,促進液晶配向膜中之電荷移動,並促進使用該液晶配向膜之液晶晶胞(cell)之電荷釋放的化合物,較佳為添加國際公開公報WO2011/132751的69頁~73頁中所揭載之式[M1]~式[M156]所示的含氮雜環胺化合物。此胺化合物可直接添加於組成物中,但以適當溶劑使成為濃度0.1質量%~10質量%,較佳為1質量%~7質量%之溶液後再添加為佳。此溶劑只要是可溶解上述特定聚醯亞胺系聚合物的有機溶劑時,即無特別限定。 When the liquid crystal alignment treatment agent of the composition of the present invention is used as a liquid crystal alignment film, the charge movement in the liquid crystal alignment film is promoted, and the compound which releases the charge of the liquid crystal cell using the liquid crystal alignment film is promoted, preferably added. The nitrogen-containing heterocyclic amine compound represented by the formula [M1] to the formula [M156] disclosed in pages 69 to 73 of International Publication No. WO2011/132751. The amine compound may be directly added to the composition, but it is preferably added in a suitable solvent to a solution having a concentration of 0.1% by mass to 10% by mass, preferably 1% by mass to 7% by mass. The solvent is not particularly limited as long as it is an organic solvent capable of dissolving the above specific polyamidene-based polymer.

本發明之液晶配向處理劑,在不損及本發明效果之範圍內,可使用在塗佈液晶配向處理劑時,提昇液晶配向膜之膜厚均勻性或表面平滑性的化合物。此外,也可使用提昇液晶配向膜與基板之密著性的化合物等。 In the liquid crystal alignment treatment agent of the present invention, a compound which improves the film thickness uniformity or surface smoothness of the liquid crystal alignment film when the liquid crystal alignment treatment agent is applied can be used within the range which does not impair the effects of the present invention. Further, a compound or the like which enhances the adhesion between the liquid crystal alignment film and the substrate can also be used.

提昇液晶配向膜之膜厚均勻性或表面平滑性的化合物,例如有氟系界面活性劑、聚矽氧系界面活性劑、非離子系界面活性劑等。 Examples of the compound which improves the film thickness uniformity or surface smoothness of the liquid crystal alignment film include a fluorine-based surfactant, a polyfluorene-based surfactant, and a nonionic surfactant.

更具體而言,例如有EFTOP EF301、EF303、EF352(以上為TOHKEM PRODUCTS公司製)、MEGAFAC F171、F173、R-30(以上為大日本油墨公司製)、FLUORAD FC430、FC431(以上為住友3M公司製)、ASAHI GUARD AG710、SURFLONS-382、SC101、SC102、SC103、SC104、SC105、SC106(以上為旭硝子公司製)等。此等界面活性劑之使用比例係相對於液晶配向處理劑中所含有之全部聚合物成分100質量份,較佳為0.01~2質量份,更佳為0.01~1質量份。 More specifically, for example, EFTOP EF301, EF303, EF352 (above, TOHKEM PRODUCTS), MEGAFAC F171, F173, R-30 (above, manufactured by Dainippon Ink Co., Ltd.), FLUORAD FC430, FC431 (above Sumitomo 3M) ASAHI GUARD AG710, SURFLONS-382, SC101, SC102, SC103, SC104, SC105, SC106 (above is manufactured by Asahi Glass Co., Ltd.). The use ratio of the surfactants is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, based on 100 parts by mass of all the polymer components contained in the liquid crystal alignment treatment agent.

提昇液晶配向膜與基板之密著性的化合物之具體例,例如有下述所示含官能性矽烷之化合物或含環氧基之化合物。 Specific examples of the compound which improves the adhesion between the liquid crystal alignment film and the substrate include, for example, a functional decane-containing compound or an epoxy group-containing compound described below.

例如3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙基三胺、N-三甲氧基矽烷基丙基三伸乙基三胺、10-三甲氧基矽烷基-1,4,7-三氮雜癸烷、10-三乙氧基矽烷基-1,4,7-三氮 雜癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙氧基矽烷基-3,6-二氮雜壬基乙酸酯、N-苄基-3-胺基丙基三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧乙烯)(oxyethylene)-3-胺基丙基三甲氧基矽烷、N-雙(氧乙烯)-3-胺基丙基三乙氧基矽烷、乙二醇二縮水甘油醚、聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮水甘油醚、聚丙二醇二縮水甘油醚、新戊二醇二縮水甘油醚、1,6-己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2-二溴新戊二醇二縮水甘油醚、1,3,5,6-四縮水甘油基-2,4-己二醇、N,N,N’,N’,-四縮水甘油基-m-二甲苯二胺、1,3-雙(N,N-二縮水甘油基胺基甲基)環己烷或N,N,N’,N’,-四縮水甘油基-4,4’-二胺基二苯基甲烷等。 For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N-( 2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-ureidopropyl Trimethoxydecane, 3-ureidopropyltriethoxydecane, N-ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyltriethyl Oxydecane, N-triethoxydecylpropyltriethylamine, N-trimethoxydecylpropyltriethylamine, 10-trimethoxydecyl-1,4,7 - triazadecane, 10-triethoxydecyl-1,4,7-triazole Heteroane, 9-trimethoxydecyl-3,6-diazaindolyl acetate, 9-triethoxydecyl-3,6-diazaindolyl acetate, N-benzyl 3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyltriethoxydecane, N-phenyl-3-aminopropyltrimethoxydecane, N-phenyl 3-aminopropyltriethoxydecane, N-bis(oxyethylene)-3-aminopropyltrimethoxydecane, N-bis(oxyethylene)-3-aminopropyltri Ethoxy decane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4 -hexanediol, N,N,N',N',-tetraglycidyl-m-xylylenediamine, 1,3-bis(N,N-diglycidylaminomethyl)cyclohexane Or N, N, N', N', -tetraglycidyl-4,4'-diaminodiphenylmethane, and the like.

使用與此等基板密著的化合物時,相對於液晶配向處理劑中所含有的全部聚合物成分100質量份,較佳為0.1~30質量份,更佳為1~20質量份。當未達0.1質量份時,無法期待提昇密著性的效果,當變得多於30質量份時,液晶配向處理劑之保存穩定性有變差的情形。 When the compound to be adhered to the substrate is used, it is preferably 0.1 to 30 parts by mass, and more preferably 1 to 20 parts by mass, based on 100 parts by mass of all the polymer components contained in the liquid crystal alignment treatment agent. When the amount is less than 0.1 part by mass, the effect of improving the adhesion property cannot be expected, and when it is more than 30 parts by mass, the storage stability of the liquid crystal alignment treatment agent may be deteriorated.

本發明之液晶配向處理劑中,除了上述弱溶劑、交聯性化合物、促進液晶晶胞(cell)之電荷釋放的化合物及提昇液晶配向膜之膜厚均勻性或表面平滑性的化合物外,只要在不損及本發明效果的範圍時,可添加改變液晶配向膜之介電率或導電性等之電特性為目的之介電質 或導電物質。 In the liquid crystal alignment treatment agent of the present invention, in addition to the above-mentioned weak solvent, a crosslinkable compound, a compound which promotes charge release of a liquid crystal cell, and a compound which improves film thickness uniformity or surface smoothness of the liquid crystal alignment film, A dielectric substance for the purpose of changing the electrical properties such as the dielectric constant or the conductivity of the liquid crystal alignment film may be added without impairing the effect of the present invention. Or conductive material.

<液晶配向膜‧液晶顯示元件> <Liquid alignment film ‧ Liquid crystal display element>

本發明之液晶配向處理劑係塗佈於基板,經燒成後,以摩擦處理或光照射等進行配向處理,可作為液晶配向膜使用。又,在垂直配向用途等的情形,即使未經配向處理也可作為液晶配向膜使用。此時所使用的基板,只要是透明性高的基板時,即無特別限定,除了玻璃基板外,也可使用丙烯酸基板或聚碳酸酯基板等之塑膠基板等。從製程簡化的觀點,較佳為使用形成有驅動液晶用之ITO電極等的基板。又,反射型液晶顯示元件,若僅為單側之基板時,也可使用矽晶圓等之不透明的基板,此時的電極也可使用鋁等會反射光的材料。 The liquid crystal alignment treatment agent of the present invention is applied to a substrate, and after firing, it is subjected to alignment treatment by rubbing treatment or light irradiation, and can be used as a liquid crystal alignment film. Moreover, in the case of a vertical alignment use or the like, it can be used as a liquid crystal alignment film even without alignment treatment. The substrate to be used in this case is not particularly limited as long as it is a substrate having high transparency, and a plastic substrate such as an acrylic substrate or a polycarbonate substrate may be used in addition to the glass substrate. From the viewpoint of process simplification, it is preferred to use a substrate on which an ITO electrode or the like for driving a liquid crystal is formed. Further, when the reflective liquid crystal display element is only a single-sided substrate, an opaque substrate such as a germanium wafer may be used. In this case, a material such as aluminum that reflects light may be used as the electrode.

液晶配向處理劑之塗佈方法無特別限定,但一般工業上係以網版印刷、平板印刷、凸版印刷或噴墨法等來進行。其他塗佈方法例如有浸漬法、輥塗佈法、狹縫塗佈法、旋轉塗佈法或噴霧法等,可因應目的而使用此等。 The coating method of the liquid crystal alignment treatment agent is not particularly limited, but is generally carried out industrially by screen printing, lithography, letterpress printing, or inkjet method. Other coating methods include, for example, a dipping method, a roll coating method, a slit coating method, a spin coating method, or a spray method, and the like can be used depending on the purpose.

將液晶配向處理劑塗佈於基板上後,藉由加熱板、熱循環型烘箱或IR(紅外線)型烘箱等之加熱手段,配合使用於液晶配向處理劑的溶劑,以30~300℃,較佳為30~250℃的溫度,使溶劑蒸發,而成為液晶配向膜。燒成後的液晶配向膜之厚度,若過厚時,在液晶顯示元件之消耗電力方面較為不利,若過薄時,液晶顯示元件 之可靠性有時會降低,故較佳為5~300nm,更佳為10~100nm。使液晶水平配向或傾斜配向時,將燒成後之液晶配向膜以摩擦或偏光紫外線照射等進行處理。 After the liquid crystal alignment treatment agent is applied onto the substrate, the solvent used in the liquid crystal alignment treatment agent is blended at 30 to 300 ° C by a heating means such as a hot plate, a heat cycle type oven, or an IR (infrared) type oven. Preferably, the temperature is 30 to 250 ° C, and the solvent is evaporated to become a liquid crystal alignment film. When the thickness of the liquid crystal alignment film after firing is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and if it is too thin, the liquid crystal display element The reliability is sometimes lowered, so it is preferably 5 to 300 nm, more preferably 10 to 100 nm. When the liquid crystal is aligned horizontally or obliquely, the liquid crystal alignment film after firing is treated by rubbing or polarized ultraviolet irradiation or the like.

本發明之液晶顯示元件係藉由上述手法,由本發明之液晶配向處理劑得到附有液晶配向膜的基板後,以習知的方法製作液晶晶胞,製成液晶顯示元件者。舉一例,一種具備下述液晶晶胞之液晶顯示元件,該液晶晶胞具有:對向配置之2片基板;設置於該基板間之液晶層;設置於該基板與液晶層間,由本發明之液晶配向處理劑所形成的上述液晶配向膜。這種本發明之液晶顯示元件,例如有垂直配向(VA:Vertical Alignment)方式或水平配向(IPS:In-Plane Switching)方式、扭轉向列(TN:Twisted Nematic)方式、OCB配向(OCB:Optically Compensated Bend)等各種者,也可為PSA(Polymer Sustained Alignment)方式等的方式。又,液晶配向膜可設置於2片基板中之至少一方。 In the liquid crystal display device of the present invention, a substrate having a liquid crystal alignment film is obtained from the liquid crystal alignment treatment agent of the present invention by the above-described method, and a liquid crystal cell is produced by a known method to obtain a liquid crystal display element. For example, a liquid crystal display device having a liquid crystal cell having two substrates disposed opposite to each other, a liquid crystal layer disposed between the substrates, and a liquid crystal layer disposed between the substrate and the liquid crystal layer The liquid crystal alignment film formed by the alignment treatment agent. Such a liquid crystal display element of the present invention has, for example, a vertical alignment (VA: Vertical Alignment) method or an IPS (In-Plane Switching) method, a twisted nematic (TN: Twisted Nematic) method, and an OCB alignment (OCB: Optically). Compensated Bend) and the like may also be a PSA (Polymer Sustained Alignment) method or the like. Further, the liquid crystal alignment film may be provided on at least one of the two substrates.

液晶晶胞之製作方法,例如有準備形成有液晶配向膜之一對基板,於單面基板之液晶配向膜上散布間隔物(spacer),使液晶配向膜面成為內側,貼合另一單面基板,減壓注入液晶後密封的方法,或將液晶滴下於散布有間隔物之液晶配向膜面後,貼合基板進行密封的方法等。 In the method for producing a liquid crystal cell, for example, a pair of substrates on which a liquid crystal alignment film is to be formed is formed, and a spacer is spread on a liquid crystal alignment film of a single-sided substrate, so that the liquid crystal alignment film surface is inside, and the other single side is bonded. A method of sealing a substrate by injecting a liquid crystal into a reduced pressure, or a method of sealing a liquid crystal onto a liquid crystal alignment film surface on which a spacer is dispersed, and bonding the substrate to perform sealing.

如上述,使用本發明之液晶配向處理劑所製造的液晶顯示元件係因具有即使長時間之光照射後,也可 抑制電壓保持率之降低的液晶配向膜,因此成為可靠性優異者,且可適用於大畫面且高精細的液晶電視等。 As described above, the liquid crystal display element produced by using the liquid crystal alignment treatment agent of the present invention can be used even after long-time light irradiation. Since the liquid crystal alignment film having a reduced voltage holding ratio is suppressed, it is excellent in reliability, and can be applied to a liquid crystal television having a large screen and a high definition.

以下更詳細說明本發明之實施形態。 Hereinafter, embodiments of the present invention will be described in more detail.

[實施例] [Examples]

以下舉實施例,更詳細說明本發明,但本發明並不限定於此等。 Hereinafter, the present invention will be described in more detail with reference to examples but the present invention is not limited thereto.

在合成例、實施例所使用的簡稱如下述。 The abbreviations used in the synthesis examples and examples are as follows.

<四羧酸二酐> <tetracarboxylic dianhydride> (特定四羧酸二酐) (specific tetracarboxylic dianhydride)

A1:下述式[A1]表示之四羧酸二酐 A1: tetracarboxylic dianhydride represented by the following formula [A1]

(特定脂肪族四羧酸二酐) (specific aliphatic tetracarboxylic dianhydride)

A2:1,2,3,4-環丁烷四羧酸二酐(下述式[A2]表示之四羧酸二酐) A2: 1,2,3,4-cyclobutanetetracarboxylic dianhydride (tetracarboxylic dianhydride represented by the following formula [A2])

A3:雙環[3.3.0]辛烷-2,4,6,8-四羧酸二酐(下述式[A3]表示之四羧酸二酐) A3: Bicyclo[3.3.0]octane-2,4,6,8-tetracarboxylic dianhydride (tetracarboxylic dianhydride represented by the following formula [A3])

A4:下述式[A4]表示之四羧酸二酐 A4: tetracarboxylic dianhydride represented by the following formula [A4]

A5:下述式[A5]表示之四羧酸二酐 A5: tetracarboxylic dianhydride represented by the following formula [A5]

(其他四羧酸二酐) (other tetracarboxylic dianhydride)

A6:均苯四酸二酐(下述式[A6]表示之四羧酸二酐) A6: pyromellitic dianhydride (tetracarboxylic dianhydride represented by the following formula [A6])

<二胺成分> <Diamine component>

B1:1,3-二胺基-4-〔4-(反式-4-n-庚基環己基)苯氧基]苯(下述式[B1]所示的二胺化合物) B1: 1,3-diamino-4-[4-(trans-4-n-heptylcyclohexyl)phenoxy]benzene (diamine compound represented by the following formula [B1])

B2:1,3-二胺基-5-〔4-(反式-4-n-庚基環己基)苯氧基甲基]苯(下述式[B2]所示的二胺化合物) B2: 1,3-diamino-5-[4-(trans-4-n-heptylcyclohexyl)phenoxymethyl]benzene (diamine compound represented by the following formula [B2])

B3:1,3-二胺基-4-{4-〔反式-4-(反式-4-n-戊基環己基)環己基]苯氧基}苯(下述式[B3]所示的二胺化合物) B3: 1,3-diamino-4-{4-[trans-4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxy}benzene (hereinafter, the formula [B3] Diamine compound

B4:1,3-二胺基-5-{4-[4-(反式-4-n-戊基環己基)環己基]苯氧基甲基}苯(下述式[B4]所示的二胺化合物) B4: 1,3-diamino-5-{4-[4-(trans-4-n-pentylcyclohexyl)cyclohexyl]phenoxymethyl}benzene (shown by the following formula [B4] Diamine compound)

B5:以下述式[B5]所示的特定側鏈型二胺化合物 B5: a specific side chain type diamine compound represented by the following formula [B5]

B6:1,3-二胺基-4-十八烷基氧基苯(下述式[B6]所示的二胺化合物) B6: 1,3-diamino-4-octadecyloxybenzene (diamine compound represented by the following formula [B6])

B7:m-苯二胺(下述式[B7]所示的二胺化合物) B7: m-phenylenediamine (diamine compound represented by the following formula [B7])

B8:p-苯二胺(下述式[B8]所示的二胺化合物) B8: p-phenylenediamine (diamine compound represented by the following formula [B8])

B9:3,5-二胺基苯甲酸(下述式[B9]所示的二胺化合物) B9: 3,5-diaminobenzoic acid (diamine compound represented by the following formula [B9])

B10:下述式[B10]所示的二胺化合物 B10: a diamine compound represented by the following formula [B10]

<有機溶劑> <organic solvent> (極性溶劑) (polar solvent)

NMP:N-甲基-2-吡咯烷酮 NMP: N-methyl-2-pyrrolidone

NEP:N-乙基-2-吡咯烷酮 NEP: N-ethyl-2-pyrrolidone

G-BL:γ-丁內酯 G-BL: γ-butyrolactone

(其他有機溶劑) (other organic solvents)

BCS:2-丁氧基乙醇 BCS: 2-butoxyethanol

PB:丙二醇單丁醚 PB: propylene glycol monobutyl ether

<聚醯亞胺前驅物及聚醯亞胺之分子量測定> <Measurement of molecular weight of polyimine precursor and polyimine]

在合成例中的聚醯亞胺前驅物及聚醯亞胺之分子量係使用常溫凝膠滲透色譜法(GPC)裝置(GPC-101)(昭 和電工公司製)、管柱(KD-803,KD-805)(Shodex公司製),如以下方式測定。 The molecular weight of the polyimine precursor and the polyimine in the synthesis example is a room temperature gel permeation chromatography (GPC) device (GPC-101). The column (KD-803, KD-805) (manufactured by Shodex Co., Ltd.) was measured as follows.

管柱溫度:50℃ Column temperature: 50 ° C

溶離液:N,N’-二甲基甲醯胺(添加劑為溴化鋰-水合物(LiBr‧H2O)為30mmol/L(公升)、磷酸‧無水結晶(o-磷酸)為30mmol/L、四氫呋喃(THF)為10ml/L) Solvent: N,N'-dimethylformamide (additive is lithium bromide-hydrate (LiBr‧H 2 O) is 30 mmol / L (liter), phosphoric acid ‧ anhydrous crystal (o-phosphoric acid) is 30 mmol / L, Tetrahydrofuran (THF) is 10ml/L)

流速:1.0ml/分鐘 Flow rate: 1.0ml/min

檢量線製作用標準樣品(sample):TSK標準聚環氧乙烷(分子量;約900,000、150,000、100,000及30,000)(TOSOH公司製)及聚乙二醇(分子量;約12,000、4,000及1,000)(Polymer Laboratories公司製)。 Standard sample for the production of calibration lines: TSK standard polyethylene oxide (molecular weight; about 900,000, 150,000, 100,000 and 30,000) (manufactured by TOSOH) and polyethylene glycol (molecular weight; about 12,000, 4,000 and 1,000) (manufactured by Polymer Laboratories).

(聚醯亞胺之醯亞胺化率之測定) (Determination of the imidization rate of polyfluorene imine)

在合成例中的聚醯亞胺之醯亞胺化率係如下述方式測定。將聚醯亞胺粉末20mg置入NMR(核磁共振)樣品管中(NMR取樣管標準, 5(草野科學公司製))中,添加重氫化二甲基亞碸(DMSO-d6,0.05質量%TMS(四甲基矽烷)混合品)(0.53ml),並施加超音波使完全溶解。將此溶液以NMR測定機(JNW-ECA500)(日本電子DATUM公司製)測定500MHz之質子NMR。醯亞胺化率係以來自醯亞胺化前後不會變化之結構之質子作為基準質子來決定,使用此質子之波峰累積值與來自出現於9.5ppm~10.0ppm附近之醯胺酸之NH基的質子波峰累積值,依以下式而求得。 The ruthenium imidization ratio of the polyimine in the synthesis example was measured as follows. 20 mg of polyimine powder was placed in an NMR (nuclear magnetic resonance) sample tube (NMR sampling tube standard, 5 (manufactured by Kusano Scientific Co., Ltd.) was added with hydrogenated dimethyl hydrazine (DMSO-d6, 0.05% by mass of TMS (tetramethyl decane) mixed product) (0.53 ml), and ultrasonic waves were applied to completely dissolve. This solution was measured for proton NMR at 500 MHz by an NMR measuring machine (JNW-ECA500) (manufactured by JEOL DATUM Co., Ltd.). The sulfhydrylation rate is determined by using protons from a structure that does not change before and after imidization as a reference proton, and the peak value of the proton is used and the NH group derived from proline which is present in the vicinity of 9.5 ppm to 10.0 ppm. The cumulative value of the proton peak is obtained by the following formula.

醯亞胺化率(%)=(1-α‧x/y)×100 醯 imidization rate (%) = (1-α‧x/y) × 100

上述式中,x係來自醯胺酸之NH基之質子波峰累積值、y係基準質子之波峰累積值、α為聚醯胺酸(醯亞胺化率為0%)時,對於1個醯胺酸之NH基質子之基準質子的個數比例。 In the above formula, x is derived from the proton peak cumulative value of the NH group of the proline, the peak cumulative value of the y-based reference proton, and α is the poly-proline (the imidization ratio is 0%). The ratio of the number of reference protons of the NH proton of the amine acid.

<合成例1> <Synthesis Example 1>

將A1(3.82g,18.0mmol)、B1(4.11g,10.8mmol)、B7(2.75g,25.2mmol)在NMP(22.8g)中混合,以40℃反應5小時後,添加A2(3.53g,18.0mmol)與NMP(18.7g),以40℃反應6小時,得到固形分濃度為20.0質量%的聚醯胺酸溶液(A)。此聚醯胺酸之數平均分子量為11,500、重量平均分子量為38,600。 A1 (3.82 g, 18.0 mmol), B1 (4.11 g, 10.8 mmol), B7 (2.75 g, 25.2 mmol) were mixed in NMP (22.8 g), and reacted at 40 ° C for 5 hours, then A2 (3.53 g, 18.0 mmol) and NMP (18.7 g) were reacted at 40 ° C for 6 hours to obtain a polyamic acid solution (A) having a solid content concentration of 20.0% by mass. The polyamine had a number average molecular weight of 11,500 and a weight average molecular weight of 38,600.

<合成例2> <Synthesis Example 2>

將A1(3.81g,18.0mmol)、B2(4.25g,10.8mmol)、B8(2.72g,25.1mmol)在NMP(23.1g)中混合,以40℃反應5小時後,添加A2(3.52g,18.0mmol)與NMP(18.9g),以40℃反應6小時,得到固形分濃度為20.0質量%的聚醯胺酸溶液。 A1 (3.81 g, 18.0 mmol), B2 (4.25 g, 10.8 mmol), B8 (2.72 g, 25.1 mmol) were mixed in NMP (23.1 g), and reacted at 40 ° C for 5 hours, then A2 (3.52 g, 18.0 mmol) and NMP (18.9 g) were reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.01g)、吡啶(1.02g),以40℃反應4小時。將此 反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(B)。此聚醯亞胺之醯亞胺化率為50%,數平均分子量為12,500、重量平均分子量為38,200。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6% by mass, acetic anhydride (2.01 g) and pyridine (1.02 g) as a ruthenium amide catalyst were added at 40 ° C. Reaction for 4 hours. Do this The reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (B). The polyimine had a hydrazine imidation ratio of 50%, a number average molecular weight of 12,500, and a weight average molecular weight of 38,200.

<合成例3> <Synthesis Example 3>

將A1(2.83g,13.3mmol)、B6(3.76g,10.0mmol)、B10(2.72g,23.3mmol)在NMP(16.9g)中混合,以40℃反應5小時後,添加A2(3.92g,20.0mmol)與NMP(13.8g),使以40℃反應6小時,得到固形分濃度為20.0質量%的聚醯胺酸溶液。 A1 (2.83 g, 13.3 mmol), B6 (3.76 g, 10.0 mmol), B10 (2.72 g, 23.3 mmol) were mixed in NMP (16.9 g), and reacted at 40 ° C for 5 hours, then A2 (3.92 g, 20.0 mmol) and NMP (13.8 g) were reacted at 40 ° C for 6 hours to obtain a polyglycine solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.1g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.28g)、吡啶(1.18g),以40℃反應3小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(C)。此聚醯亞胺之醯亞胺化率為70%,數平均分子量為11,500、重量平均分子量為31,400。 After adding NMP to the obtained polyamic acid solution (15.1 g), and diluting it to 6 mass%, acetic anhydride (2.28g) and pyridine (1.18g) which are a ruthenium-imidation catalyst were added, and it was 40 degreeC. Reaction for 3 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (C). The polyimine had a hydrazine imidation ratio of 70%, a number average molecular weight of 11,500, and a weight average molecular weight of 31,400.

<合成例4> <Synthesis Example 4>

將A1(4.50g,21.2mmol)、B7(4.59g,42.4mmol)在NMP(21.8g)中混合,以40℃反應5小時後,添加A3(5.31g,21.2mmol)與NMP(17.8g),使以50℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸 溶液。 A1 (4.50 g, 21.2 mmol) and B7 (4.59 g, 42.4 mmol) were mixed in NMP (21.8 g), and reacted at 40 ° C for 5 hours, then A3 (5.31 g, 21.2 mmol) and NMP (17.8 g) were added. The reaction was carried out at 50 ° C for 6 hours to obtain a polyamic acid having a solid content concentration of 20.0% by mass. Solution.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.73g)、吡啶(1.60g),以40℃反應3.5小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(D)。此聚醯亞胺之醯亞胺化率為53%,數平均分子量為13,100、重量平均分子量為35,000。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6% by mass, acetic anhydride (2.73 g) and pyridine (1.60 g) as a ruthenium amide catalyst were added at 40 ° C. Reaction for 3.5 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (D). The polyimine had a ruthenium iodide ratio of 53%, a number average molecular weight of 13,100, and a weight average molecular weight of 35,000.

<合成例5> <Synthesis Example 5>

將A1(1.10g,5.19mmol)、B1(3.95g,10.4mmol)、B9(2.37g,15.6mmol)在NMP(22.9g)中混合,以40℃反應5小時後,添加A2(4.07g,20.8mmol)與NMP(18.7g),使以40℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A1 (1.10 g, 5.19 mmol), B1 (3.95 g, 10.4 mmol), B9 (2.37 g, 15.6 mmol) were mixed in NMP (22.9 g), and reacted at 40 ° C for 5 hours, then A2 (4.07 g, 20.8 mmol) and NMP (18.7 g) were reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.12g)、吡啶(1.15g),以40℃反應3小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(E)。此聚醯亞胺之醯亞胺化率為52%,數平均分子量為12,600、重量平均分子量為36,200。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6% by mass, acetic anhydride (2.12 g) and pyridine (1.15 g) as a ruthenium amide catalyst were added at 40 ° C. Reaction for 3 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (E). The polyimine had a hydrazine imidation ratio of 52%, a number average molecular weight of 12,600, and a weight average molecular weight of 36,200.

<合成例6> <Synthesis Example 6>

將A1(7.80g,36.7mmol)、B8(6.11g,56.5mmol)在NMP(22.0g)中混合,以40℃反應5小時後,添加A2(3.88g,19.8mmol)與NMP(18.0g),使以40℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液(F)。此聚醯胺酸之數平均分子量為11,200、重量平均分子量為38,500。 A1 (7.80 g, 36.7 mmol) and B8 (6.11 g, 56.5 mmol) were mixed in NMP (22.0 g), and reacted at 40 ° C for 5 hours, then A2 (3.88 g, 19.8 mmol) and NMP (18.0 g) were added. The reaction was carried out at 40 ° C for 6 hours to obtain a polyamic acid solution (F) having a solid content concentration of 20.0% by mass. The polyamine had a number average molecular weight of 11,200 and a weight average molecular weight of 38,500.

<合成例7> <Synthesis Example 7>

將A1(1.41g,6.65mmol)、B5(2.62g,5.32mmol)、B9(3.24g,21.3mmol)在NMP(23.9g)中混合,以40℃反應5小時後,添加A3(4.99g,19.9mmol)與NMP(19.5g),使以50℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液(G)。此聚醯胺酸之數平均分子量為13,500、重量平均分子量為35,600。 A1 (1.41 g, 6.65 mmol), B5 (2.62 g, 5.32 mmol), B9 (3.24 g, 21.3 mmol) were mixed in NMP (23.9 g), and reacted at 40 ° C for 5 hours, then A3 (4.99 g, 19.9 mmol) and NMP (19.5 g) were reacted at 50 ° C for 6 hours to obtain a polyamic acid solution (G) having a solid content concentration of 20.0% by mass. The polyamine had a number average molecular weight of 13,500 and a weight average molecular weight of 35,600.

<合成例8> <Synthesis Example 8>

將A1(3.06g,14.4mmol)、B3(3.74g,8.65mmol)、B10(2.47g,20.2mmol)在NMP(1.53g)中混合,以40℃反應5小時後,添加A4(3.23g,14.4mmol)與NMP(12.6g),使以50℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A1 (3.06 g, 14.4 mmol), B3 (3.74 g, 8.65 mmol), B10 (2.47 g, 20.2 mmol) were mixed in NMP (1.53 g), and reacted at 40 ° C for 5 hours, then A4 (3.23 g, 14.4 mmol) and NMP (12.6 g) were reacted at 50 ° C for 6 hours to obtain a polyamic acid solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(1.89g)、吡啶(0.90g),以50℃反應3小時。將此 反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(H)。此聚醯亞胺之醯亞胺化率為70%,數平均分子量為11,800、重量平均分子量為30,400。 After adding NMP to the obtained polyamic acid solution (15.0 g) and diluting it to 6 mass%, acetic anhydride (1.89 g) and pyridine (0.90 g) as a ruthenium amide catalyst were added at 50 ° C. Reaction for 3 hours. Do this The reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (H). The polyimine had a hydrazine imidation ratio of 70%, a number average molecular weight of 11,800, and a weight average molecular weight of 30,400.

<合成例9> <Synthesis Example 9>

將A1(2.25g,10.6mmol)、B4(2.71g,6.06mmol)、B7(1.64g,15.2mmol)、B9(1.38g,9.09mmol)在NMP(2.23g)中混合,以40℃反應5小時後,添加A4(4.42g,19.7mmol)與NMP(18.3g),使以50℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A1 (2.25 g, 10.6 mmol), B4 (2.71 g, 6.06 mmol), B7 (1.64 g, 15.2 mmol), B9 (1.38 g, 9.09 mmol) were mixed in NMP (2.23 g), and reacted at 40 ° C. After the hour, A4 (4.42 g, 19.7 mmol) and NMP (18.3 g) were added, and the mixture was reacted at 50 ° C for 6 hours to obtain a polyamic acid solution having a solid concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.20g)、吡啶(1.12g),以50℃反應3小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(I)。此聚醯亞胺之醯亞胺化率為51%,數平均分子量為11,000、重量平均分子量為30,100。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6 mass%, acetic anhydride (2.20g) and pyridine (1.12g) which are a ruthenium-imidation catalyst were added, and 50 degreeC was 50 degreeC. Reaction for 3 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (I). The polyimine had a hydrazine imidation ratio of 51%, a number average molecular weight of 11,000, and a weight average molecular weight of 30,100.

<合成例10> <Synthesis Example 10>

將A1(2.02g,9.52mmol)、B8(3.43g,31.7mmol)在NMP(22.2g)中混合,以40℃反應5小時後,添加A5(6.67g,22.2mmol)與NMP(18.2g),使以25 ℃反應12小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液(J)。此聚醯胺酸之數平均分子量為11,800、重量平均分子量為36,300。 A1 (2.02 g, 9.52 mmol) and B8 (3.43 g, 31.7 mmol) were mixed in NMP (22.2 g), and reacted at 40 ° C for 5 hours, then A5 (6.67 g, 22.2 mmol) and NMP (18.2 g) were added. To make 25 The reaction was carried out at ° C for 12 hours to obtain a polyamic acid solution (J) having a solid content concentration of 20.0% by mass. The polyamine had a number average molecular weight of 11,800 and a weight average molecular weight of 36,300.

<合成例11> <Synthesis Example 11>

將A1(11.2g,52.9mmol)、B1(6.04g,15.9mmol)、B7(4.01g,37.1mmol)在NMP(40.2g)中混合,使以40℃反應24小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液(K)。此聚醯胺酸之數平均分子量為7,100、重量平均分子量為29,800。 A1 (11.2 g, 52.9 mmol), B1 (6.04 g, 15.9 mmol), B7 (4.01 g, 37.1 mmol) were mixed in NMP (40.2 g), and reacted at 40 ° C for 24 hours to obtain a solid concentration of 20.0. Mass % polyaminic acid solution (K). The polyamine had a number average molecular weight of 7,100 and a weight average molecular weight of 29,800.

<合成例12> <Synthesis Example 12>

將A2(5.10g,26.0mmol)、B6(2.94g,7.80mmol)、B10(2.22g,18.2mmol)在NMP(32.2g)中混合,使以40℃反應8小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A2 (5.10 g, 26.0 mmol), B6 (2.94 g, 7.80 mmol), B10 (2.22 g, 18.2 mmol) were mixed in NMP (32.2 g), and reacted at 40 ° C for 8 hours to obtain a solid concentration of 20.0. Mass% polyamine solution.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(2.00g)、吡啶(1.01g),以40℃反應3小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(L)。此聚醯亞胺之醯亞胺化率為70%,數平均分子量為13,800、重量平均分子量為35,600。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6 mass %, acetic anhydride (2.00g) and pyridine (1.01g) which are a ruthenium-imidation catalyst were added, and it was 40 degreeC. Reaction for 3 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (L). The polyimine had a hydrazine imidation ratio of 70%, a number average molecular weight of 13,800, and a weight average molecular weight of 35,600.

<合成例13> <Synthesis Example 13>

將A3(3.80g,15.2mmol)、B7(3.29g,30.4mmol)在NMP(22.2g)中混合,以50℃反應3小時後,添加A2(2.98g,15.2mmol)與NMP(18.1g),以40℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A3 (3.80 g, 15.2 mmol) and B7 (3.29 g, 30.4 mmol) were mixed in NMP (22.2 g), and reacted at 50 ° C for 3 hours, then A2 (2.98 g, 15.2 mmol) and NMP (18.1 g) were added. The reaction was carried out at 40 ° C for 6 hours to obtain a polyamic acid solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(3.10g)、吡啶(1.52g),以50℃反應3.5小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(M)。此聚醯亞胺之醯亞胺化率為50%,數平均分子量為14,700、重量平均分子量為37,100。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6% by mass, acetic anhydride (3.10 g) and pyridine (1.52 g) as a ruthenium amide catalyst were added at 50 ° C. Reaction for 3.5 hours. This reaction solution was poured into methanol (350 ml), and the obtained precipitate was obtained by filtration. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (M). The polyimine had a hydrazine imidation ratio of 50%, a number average molecular weight of 14,700, and a weight average molecular weight of 37,100.

<合成例14> <Synthesis Example 14>

將A1(1.03g,4.85mmol)、B1(3.70g,9.71mmol)、B9(2.22g,14.6mmol)在NMP(22.3g)中混合,以40℃反應5小時後,添加A6(4.24g,19.4mmol)與NMP(18.3g),以40℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液。 A1 (1.03 g, 4.85 mmol), B1 (3.70 g, 9.71 mmol), B9 (2.22 g, 14.6 mmol) were mixed in NMP (22.3 g), and reacted at 40 ° C for 5 hours, then A6 (4.24 g, 19.4 mmol) and NMP (18.3 g) were reacted at 40 ° C for 6 hours to obtain a polyamic acid solution having a solid content concentration of 20.0% by mass.

在所製得之聚醯胺酸溶液(15.0g)中添加NMP,稀釋成6質量%後,添加作為醯亞胺化觸媒之乙酸酐(1.86g)、吡啶(0.98g),以40℃反應3小時。將此反應溶液投入甲醇(350ml)中,所得之沈澱物經過濾取 得。此沈澱物以甲醇洗淨,以60℃減壓乾燥得到聚醯亞胺粉末(N)。此聚醯亞胺之醯亞胺化率為52%,數平均分子量為13,800、重量平均分子量為34,700。 After adding NMP to the obtained polyamic acid solution (15.0 g), and diluting it to 6 mass%, acetic anhydride (1.86g) and pyridine (0.98g) which are a ruthenium-imidation catalyst were added, and it was 40 degreeC. Reaction for 3 hours. The reaction solution was poured into methanol (350 ml), and the resulting precipitate was filtered. Got it. This precipitate was washed with methanol, and dried under reduced pressure at 60 ° C to obtain a polyimine powder (N). The polyimine had a hydrazine imidation ratio of 52%, a number average molecular weight of 13,800, and a weight average molecular weight of 34,700.

<合成例15> <Synthesis Example 15>

將A6(4.52g,20.7mmol)、B8(3.45g,31.9mmol)在NMP(22.4g)中混合,以40℃反應5小時後,添加A2(2.19g,11.2mmol)與NMP(18.3g),以40℃反應6小時,得到固形分濃度為20.0質量%之聚醯胺酸溶液(O)。此聚醯胺酸之數平均分子量為16,100、重量平均分子量為42,000。 A6 (4.52 g, 20.7 mmol) and B8 (3.45 g, 31.9 mmol) were mixed in NMP (22.4 g), and reacted at 40 ° C for 5 hours, then A2 (2.19 g, 11.2 mmol) and NMP (18.3 g) were added. The reaction was carried out at 40 ° C for 6 hours to obtain a polyamic acid solution (O) having a solid content concentration of 20.0% by mass. The polyamine had a number average molecular weight of 16,100 and a weight average molecular weight of 42,000.

表1係表示以合成例1~15所得之聚醯胺酸及聚醯亞胺。 Table 1 shows the polyamic acid and polyimine obtained in Synthesis Examples 1 to 15.

<實施例1> <Example 1>

將合成例1所得之固形分濃度20.0質量%之聚醯胺酸溶液(A)(9.03g)、NMP(8.90g)及BCS(12.0g),以25℃混合8小時,得到液晶配向處理劑(1)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyamidic acid solution (A) (9.03 g), NMP (8.90 g), and BCS (12.0 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 1 were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent. (1). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(1),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (1), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例2> <Example 2>

將合成例2所得之聚醯亞胺粉末(B)(1.80g)、NMP(9.02g)、NEP(7.51g)及BCS(13.5g),以25℃混合8小時,得到液晶配向處理劑(2)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (B) (1.80 g) obtained in Synthesis Example 2, NMP (9.02 g), NEP (7.51 g), and BCS (13.5 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent ( 2). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(2),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (2), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例3> <Example 3>

將合成例2所得之聚醯亞胺粉末(B)(1.50g)、NMP(12.4g)、NEP(10.3g)及BCS(18.6g)以25℃混合8小時,得到液晶配向處理劑(3)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (B) (1.50 g) obtained in Synthesis Example 2, NMP (12.4 g), NEP (10.3 g), and BCS (18.6 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (3). ). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(3),以上述條件進行「液晶配向處理劑之噴墨塗佈性之評價」。 Using the obtained liquid crystal alignment treatment agent (3), "evaluation of inkjet coating property of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例4> <Example 4>

將合成例3所得之聚醯亞胺粉末(C)(1.80g)、NMP(9.01g)、G-BL(9.02g)及BCS(12.0g)以25℃混合8小時,得到液晶配向處理劑(4)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (C) (1.80 g) obtained in Synthesis Example 3, NMP (9.01 g), G-BL (9.02 g), and BCS (12.0 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent. (4). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(4),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (4), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例5> <Example 5>

將合成例4所得之聚醯亞胺粉末(D)(1.80g)、NMP(7.53g)、NEP(12.1g)、G-BL(1.53g)及PB(9.11g)以25℃混合8小時,得到液晶配向處理劑(5)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (D) (1.80 g) obtained in Synthesis Example 4, NMP (7.53 g), NEP (12.1 g), G-BL (1.53 g), and PB (9.11 g) were mixed at 25 ° C for 8 hours. A liquid crystal alignment treatment agent (5) was obtained. It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(5),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (5), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例6> <Example 6>

將合成例5所得之聚醯亞胺粉末(E)(1.79g)、NMP(9.00g)、NEP(14.5g)、BCS(3.02g)及PB(3.00g)以25℃混合8小時,得到液晶配向處理劑(6)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (E) (1.79 g) obtained in Synthesis Example 5, NMP (9.00 g), NEP (14.5 g), BCS (3.02 g), and PB (3.00 g) were mixed at 25 ° C for 8 hours to obtain Liquid crystal alignment treatment agent (6). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(6),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (6), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例7> <Example 7>

將合成例5所得之聚醯亞胺粉末(E)(1.50g)、NMP(8.27g)、NEP(16.5g)及PB(16.5g)以25℃混合8小時,得到液晶配向處理劑(7)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (E) (1.50 g) obtained in Synthesis Example 5, NMP (8.27 g), NEP (16.5 g), and PB (16.5 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (7). ). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(7),以上述條件進行「液晶配向處理劑之噴墨塗佈性之評價」。 Using the obtained liquid crystal alignment treatment agent (7), "evaluation of inkjet coating property of liquid crystal alignment treatment agent" was carried out under the above conditions.

<實施例8> <Example 8>

將合成例6所得之固形分濃度20.0質量%的聚醯胺酸溶液(F)(9.00g)、NMP(3.00g)、G-BL(9.06g)及BCS(9.01g)以25℃混合8小時,得到液晶配向處理劑(8)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 Polylysine solution (F) (9.00 g), NMP (3.00 g), G-BL (9.06 g), and BCS (9.01 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 6 were mixed at 25 ° C. The liquid crystal alignment treatment agent (8) was obtained in an hour. It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(8),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (8), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例9> <Example 9>

將合成例7所得之固形分濃度20.0質量%的聚醯胺酸溶液(G)(9.01g)、NEP(9.02g)、G-BL(9.02g)、BCS(6.01g)及PB(6.00g)以25℃混合8小時,得到液晶配向處理劑(9)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 Polylysine solution (G) (9.01 g), NEP (9.02 g), G-BL (9.02 g), BCS (6.01 g), and PB (6.00 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 7. The mixture was mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (9). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(9),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (9), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例10> <Example 10>

將合成例8所得之聚醯亞胺粉末(H)(1.80g)、NMP(6.00g)、NEP(6.05g)、BCS(6.04g)及PB(3.01g)以25℃混合8小時,得到液晶配向處理劑(10)。確認此液晶配向處理劑未發現混濁及析出等異 常,且為均勻的溶液。 The polyimine powder (H) (1.80 g), NMP (6.00 g), NEP (6.05 g), BCS (6.04 g) and PB (3.01 g) obtained in Synthesis Example 8 were mixed at 25 ° C for 8 hours to obtain Liquid crystal alignment treatment agent (10). It was confirmed that no turbidity and precipitation were observed in the liquid crystal alignment agent. Often, it is a homogeneous solution.

使用所得之液晶配向處理劑(10),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (10), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例11> <Example 11>

將合成例9所得之聚醯亞胺粉末(I)(1.80g)、NMP(12.0g)、NEP(9.00g)及BCS(9.05g)以25℃混合8小時,得到液晶配向處理劑(11)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (I) (1.80 g) obtained in Synthesis Example 9, NMP (12.0 g), NEP (9.00 g), and BCS (9.05 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (11). ). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(11),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (11), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<實施例12> <Example 12>

將合成例10所得之固形分濃度20.0質量%的聚醯胺酸溶液(J)(9.04g)、NMP(16.5g)、NEP(9.02g)及PB(4.50g)以25℃混合8小時,得到液晶配向處理劑(12)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 Polylysine solution (J) (9.04 g), NMP (16.5 g), NEP (9.02 g), and PB (4.50 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 10 were mixed at 25 ° C for 8 hours. A liquid crystal alignment treatment agent (12) was obtained. It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(12),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (12), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<比較例1> <Comparative Example 1>

將合成例11所得之固形分濃度20.0質量%的聚醯胺酸溶液(K)(9.03g)、NMP(9.31g)及BCS(12.2g) 以25℃混合8小時,得到液晶配向處理劑(13)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 Polylysine solution (K) (9.03 g), NMP (9.31 g), and BCS (12.2 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 11. The mixture was mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent (13). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(13),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (13), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<比較例2> <Comparative Example 2>

將合成例12所得之聚醯亞胺粉末(L)(1.80g)、NMP(9.00g)、G-BL(9.02g)及BCS(12.0g)以25℃混合8小時,得到液晶配向處理劑(14)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (L) (1.80 g) obtained in Synthesis Example 12, NMP (9.00 g), G-BL (9.02 g), and BCS (12.0 g) were mixed at 25 ° C for 8 hours to obtain a liquid crystal alignment treatment agent. (14). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(14),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (14), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<比較例3> <Comparative Example 3>

將合成例13所得之聚醯亞胺粉末(M)(1.80g)、NMP(7.50g)、NEP(12.0g)、G-BL(1.50g)及PB(9.00g)以25℃混合8小時,得到液晶配向處理劑(15)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (M) (1.80 g) obtained in Synthesis Example 13, NMP (7.50 g), NEP (12.0 g), G-BL (1.50 g), and PB (9.00 g) were mixed at 25 ° C for 8 hours. A liquid crystal alignment treatment agent (15) was obtained. It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(15),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (15), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<比較例4> <Comparative Example 4>

將合成例14所得之聚醯亞胺粉末(N)(1.80g)、NMP(9.00g)、NEP(15.0g)、BCS(3.06g)及PB(3.03g)以25℃混合8小時,得到液晶配向處理劑(16)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 The polyimine powder (N) (1.80 g) obtained in Synthesis Example 14, NMP (9.00 g), NEP (15.0 g), BCS (3.06 g), and PB (3.03 g) were mixed at 25 ° C for 8 hours to obtain Liquid crystal alignment treatment agent (16). It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(16),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (16), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

<比較例5> <Comparative Example 5>

將合成例15所得之固形分濃度20.0質量%的聚醯胺酸溶液(O)(9.05g)、NMP(3.00g)、G-BL(9.02g)及BCS(9.00g)以25℃混合8小時,得到液晶配向處理劑(17)。確認此液晶配向處理劑未發現混濁及析出等異常,且為均勻的溶液。 Polylysine solution (O) (9.05 g), NMP (3.00 g), G-BL (9.02 g), and BCS (9.00 g) having a solid content concentration of 20.0% by mass obtained in Synthesis Example 15 were mixed at 25 ° C. The liquid crystal alignment treatment agent (17) was obtained in an hour. It was confirmed that this liquid crystal alignment treatment agent was found to have no abnormality such as turbidity and precipitation, and was a uniform solution.

使用所得之液晶配向處理劑(17),以上述條件進行「液晶晶胞之製作及電特性之評價」。 Using the obtained liquid crystal alignment treatment agent (17), "production of liquid crystal cell and evaluation of electrical characteristics" were carried out under the above conditions.

使用本發明之各實施例及各比較例所得之液 晶配向處理劑,進行「液晶晶胞之製作」、「電特性(電壓保持率)之評價」及「液晶配向處理劑之噴墨塗佈性之評價」。其條件如下述。 Using the liquid obtained in each of the examples and comparative examples of the present invention In the crystal alignment treatment, "production of liquid crystal cell", "evaluation of electrical characteristics (voltage holding ratio)", and "evaluation of inkjet coating property of liquid crystal alignment treatment agent" were performed. The conditions are as follows.

表1及表2係表示實施例1~12及比較例1~5 所得之液晶配向處理劑所含有之特定聚合物的原料(四羧酸二酐及二胺成分)。 Tables 1 and 2 show Examples 1 to 12 and Comparative Examples 1 to 5 The raw material (tetracarboxylic dianhydride and diamine component) of the specific polymer contained in the obtained liquid crystal alignment treatment agent.

<液晶晶胞之製作及電特性之評價> <Production of liquid crystal cell and evaluation of electrical characteristics>

將實施例1、2、4~6、8~12及比較例1~5所得之液晶配向處理劑,以細孔徑1μm之薄膜過濾器進行加壓過濾,製作液晶晶胞。將此溶液旋轉塗佈於以純水及IPA(異丙醇)洗淨後之30×40mm之附有ITO電極之基板(縱40mm×橫30mm、厚度0.7mm)的ITO面上,於加熱板上以80℃加熱處理5分鐘,在熱循環型無塵烘箱中以230℃加熱處理30分鐘,得到膜厚100nm之附聚醯亞胺液晶配向膜的ITO基板。將此ITO基板之塗膜面以輥徑為120mm之摩擦裝置,使用嫘縈布以輥旋轉數為1000rpm、輥行進速度為50mm/sec、壓入量為0.1mm的條件下進行摩擦處理。 The liquid crystal alignment treatment agents obtained in Examples 1, 2, 4 to 6, 8 to 12 and Comparative Examples 1 to 5 were subjected to pressure filtration using a membrane filter having a pore diameter of 1 μm to prepare a liquid crystal cell. This solution was spin-coated on an ITO surface of a 30×40 mm substrate (length 40 mm × width 30 mm, thickness 0.7 mm) of ITO electrode washed with pure water and IPA (isopropyl alcohol) on a heating plate. The film was heat-treated at 80 ° C for 5 minutes, and heat-treated at 230 ° C for 30 minutes in a heat cycle type dust-free oven to obtain an ITO substrate of an agglomerated iridium imine liquid crystal alignment film having a thickness of 100 nm. The coating film surface of this ITO substrate was rubbed by a rubbing apparatus having a roll diameter of 120 mm, and the rubbing was performed under the conditions of a roll rotation number of 1000 rpm, a roll travel speed of 50 mm/sec, and a press-in amount of 0.1 mm.

將所得之附有液晶配向膜的ITO基板準備2片,以液晶配向膜面為內側,夾住6μm的間隔物並組合後,印刷密封劑(XN-1500T)(三井化學公司製)。接著,另一方的基板與液晶配向膜面以對向的方式貼合後,將密封劑在熱循環型無塵烘箱中,以150℃加熱處理90分鐘,經硬化後製作空晶胞。在此空晶胞中,藉由減壓注入法,注入液晶並密封注入口後得到液晶晶胞。 Two sheets of the ITO substrate with the liquid crystal alignment film obtained were prepared, and the liquid crystal alignment film surface was placed inside, and a 6 μm spacer was sandwiched and combined, and then a sealant (XN-1500T) (manufactured by Mitsui Chemicals, Inc.) was printed. Next, after the other substrate and the liquid crystal alignment film surface were bonded to each other, the sealing agent was heat-treated at 150 ° C for 90 minutes in a heat cycle type dust-free oven, and was hardened to prepare an empty cell. In this empty cell, a liquid crystal cell is obtained by injecting a liquid crystal and sealing the injection port by a vacuum injection method.

此外,使用以實施例1所得之液晶配向處理劑(1)、實施例2所得之液晶配向處理劑(2)、實施例4所得之液晶配向處理劑(4)、實施例6所得之液晶配向處理劑(6)、實施例9~實施例11所得之液晶配向處理劑(9)~液晶配向處理劑(11)、比較例1所得之液晶 配向處理劑(13)、比較例2所得之液晶配向處理劑(14)及比較例4所得之液晶配向處理劑(16)的液晶晶胞中,液晶使用向列型液晶(MLC-6608)(Merck‧Japan公司製)。 Further, the liquid crystal alignment treatment agent (1) obtained in Example 1, the liquid crystal alignment treatment agent (2) obtained in Example 2, the liquid crystal alignment treatment agent (4) obtained in Example 4, and the liquid crystal alignment obtained in Example 6 were used. Liquid crystal alignment treatment agent (9) obtained by treating agent (6), and Example 9 to Example 11, liquid crystal alignment treatment agent (11), and liquid crystal obtained in Comparative Example 1. In the liquid crystal cell of the alignment treatment agent (13), the liquid crystal alignment treatment agent (14) obtained in Comparative Example 2, and the liquid crystal alignment treatment agent (16) obtained in Comparative Example 4, the liquid crystal was a nematic liquid crystal (MLC-6608) ( Merck‧Japan company).

又,使用實施例5所得之液晶配向處理劑(5)、實施例8所得之液晶配向處理劑(8)、實施例12所得之液晶配向處理劑(12)、比較例3所得之液晶配向處理劑(15)及比較例5所得之液晶配向處理劑(17)之液晶晶胞中,液晶使用向列型液晶(MLC-2041)(Merck‧Japan公司製)。 Further, the liquid crystal alignment treatment agent (5) obtained in Example 5, the liquid crystal alignment treatment agent (8) obtained in Example 8, the liquid crystal alignment treatment agent (12) obtained in Example 12, and the liquid crystal alignment treatment obtained in Comparative Example 3 were used. In the liquid crystal cell of the liquid crystal alignment agent (17) obtained in the agent (15) and the comparative example 5, nematic liquid crystal (MLC-2041) (manufactured by Merck Japan Co., Ltd.) was used for the liquid crystal.

使用以上述所得之液晶晶胞,進行液晶配向性之評價。液晶配向性係使用偏光顯微鏡(ECLIPSE E600WPOL)(Nikon公司製),觀察液晶晶胞,並確認有無配向缺陷。結果各實施例及各比較例所得之液晶晶胞均未發現配向缺陷,顯示均勻的配向性。 The liquid crystal alignment obtained by the above was used to evaluate the liquid crystal alignment. In the liquid crystal alignment, a liquid crystal cell was observed using a polarizing microscope (ECLIPSE E600WPOL) (manufactured by Nikon Co., Ltd.), and it was confirmed whether or not there was an alignment defect. As a result, no alignment defects were observed in the liquid crystal cell obtained in each of the examples and the comparative examples, and uniform alignment was exhibited.

對於以上述製作的液晶晶胞,在80℃之溫度下,1V電壓施加60μs,測定16.67ms後及50ms後之電壓,電壓可保持多少係以電壓保持率(VHR)計算。測定係使用VHR-1電壓保持率測定裝置(東陽科技公司製)以Voltage:±1V、Pulse Width:60μs、Flame Period:16.67ms或50ms之設定來進行。對於電壓保持率之測定終了後的液晶晶胞,照射以365nm換算為50J/cm2的紫外線後,與上述同樣的條件測定電壓保持率。此外,紫外線照射係使用桌上型UV硬化裝置(HCT3B28HEX-1) (SEN LIGHT製(SEN LIGHT CORPORATION))來進行。 With respect to the liquid crystal cell fabricated as described above, a voltage of 1 V was applied for 60 μs at a temperature of 80 ° C, and the voltage after 16.67 ms and after 50 ms was measured, and how much the voltage can be maintained is calculated by the voltage holding ratio (VHR). The measurement was performed using a VHR-1 voltage retention ratio measuring device (manufactured by Toyo Corporation) with a setting of Voltage: ±1 V, Pulse Width: 60 μs, Flame Period: 16.67 ms, or 50 ms. The liquid crystal cell after the measurement of the voltage holding ratio was irradiated with ultraviolet rays of 50 J/cm 2 in terms of 365 nm, and the voltage holding ratio was measured under the same conditions as above. Further, ultraviolet irradiation was carried out using a desktop type UV curing device (HCT3B28HEX-1) (manufactured by SEN LIGHT CORPORATION).

表3係表示電壓保持率之測定結果。又,電壓保持率係依存於二胺成分之種類,故使用相同二胺成分者彼此必須比較。 Table 3 shows the measurement results of the voltage holding ratio. Further, since the voltage holding ratio depends on the type of the diamine component, those who use the same diamine component must be compared with each other.

相較於由各比較例之液晶配向處理劑所得之液晶配向膜,由各實施例之液晶配向處理劑所得之液晶配向膜,即使暴露於紫外線照射,其電壓保持率之降低也變得較少。 The liquid crystal alignment film obtained from the liquid crystal alignment treatment agents of the respective examples has a lower voltage holding ratio even when exposed to ultraviolet light irradiation, compared to the liquid crystal alignment film obtained from the liquid crystal alignment treatment agents of the respective comparative examples. .

具體而言,實施例1係使用特定四羧酸二酐及特定脂肪族四羧酸二酐之2種類的四羧酸二酐,但是比較例1僅使用其中之一的特定四羧酸二酐。此外,二胺成分(B1與B7)為相同。結果藉由紫外線照射,比較例1之電壓保持率大幅降低。 Specifically, Example 1 uses two kinds of tetracarboxylic dianhydrides of a specific tetracarboxylic dianhydride and a specific aliphatic tetracarboxylic dianhydride, but Comparative Example 1 uses only one of the specific tetracarboxylic dianhydrides. . Further, the diamine components (B1 and B7) are the same. As a result, the voltage holding ratio of Comparative Example 1 was greatly lowered by ultraviolet irradiation.

同樣地,實施例4係使用2種類的四羧酸二酐,但是比較例2僅使用另一種特定脂肪族四羧酸二酐。此外,二胺成分(B6與B10)為相同。結果藉由紫外線照射,比較例2之電壓保持率更大幅降低。 Similarly, in Example 4, two types of tetracarboxylic dianhydride were used, but Comparative Example 2 used only another specific aliphatic tetracarboxylic dianhydride. Further, the diamine components (B6 and B10) are the same. As a result, the voltage holding ratio of Comparative Example 2 was further lowered by ultraviolet irradiation.

實施例5與比較例3之比較,也為同樣的結果。 The same results were obtained for the comparison of Example 5 with Comparative Example 3.

此外,實施例6與比較例4、實施例8與比較例5之比較時,將2種類之四羧酸二酐之任一方與其他的四羧酸二酐用於比較例4、5,但是比較例4、5之電壓保持率,藉由紫外線照射而大幅降低。 Further, in the comparison of Example 6 with Comparative Example 4, Example 8 and Comparative Example 5, either of the two types of tetracarboxylic dianhydrides and other tetracarboxylic dianhydrides were used for Comparative Examples 4 and 5, but The voltage holding ratios of Comparative Examples 4 and 5 were greatly reduced by ultraviolet irradiation.

此結果可知,藉由使用特定四羧酸二酐及特定脂肪族四羧酸二酐之2種類之四羧酸二酐,作為本發明之液晶配向處理劑所含有之特定聚合物的原料,可製作電壓保持率之降低被抑制,具有優異之光耐性的液晶配向膜。具有這種液晶配向膜的液晶顯示元件,即使處於長時間光照射,電壓保持率也不會降低,具有光耐性,且可靠性優異者。 As a result, it is understood that the tetracarboxylic dianhydride of the specific type of the tetracarboxylic dianhydride and the specific aliphatic tetracarboxylic dianhydride can be used as a raw material of the specific polymer contained in the liquid crystal alignment treatment agent of the present invention. A liquid crystal alignment film having excellent light resistance is suppressed in which the reduction in voltage holding ratio is suppressed. A liquid crystal display element having such a liquid crystal alignment film does not deteriorate in voltage holding ratio even when irradiated with light for a long period of time, and has light resistance and is excellent in reliability.

<液晶配向處理劑之噴墨塗佈性之評價> <Evaluation of inkjet coating property of liquid crystal alignment treatment agent>

將本發明之實施例3所得之液晶配向處理劑(3)及實施例7所得之液晶配向處理劑(7)以細孔徑1μm之薄膜過濾器進行加壓過濾,進行噴墨塗佈性評價。噴墨塗佈機使用HIS-200(日立PLANT-TECHNOLOGIES公司製)。塗佈係於以純水及IPA(異丙醇)洗淨後之ITO(氧化銦錫)蒸鍍基板上,塗佈面積為70×70mm、噴嘴間距為0.423mm、掃描間距為0.5mm、塗佈速度為40mm/秒、自塗佈至暫時乾燥為止之時間為60秒、暫時乾燥係在加熱板上以70℃、5分鐘之條件來進行。 The liquid crystal alignment treatment agent (3) obtained in Example 3 of the present invention and the liquid crystal alignment treatment agent (7) obtained in Example 7 were subjected to pressure filtration using a membrane filter having a pore diameter of 1 μm to evaluate inkjet coating properties. The inkjet coater used HIS-200 (manufactured by Hitachi PLANT-TECHNOLOGIES Co., Ltd.). The coating was applied to an ITO (Indium Tin Oxide) vapor-deposited substrate washed with pure water and IPA (isopropyl alcohol), and the coated area was 70×70 mm, the nozzle pitch was 0.423 mm, and the scanning pitch was 0.5 mm. The cloth speed was 40 mm/sec, the time from application to temporary drying was 60 seconds, and the temporary drying was performed on a hot plate at 70 ° C for 5 minutes.

各實施例可得到在所得之液晶配向膜上,未發現排斥或針孔,且為均勻塗佈的液晶配向膜。 In each of the examples, a liquid crystal alignment film which was uniformly coated was not found on the obtained liquid crystal alignment film, and no repulsion or pinhole was observed.

其中實施例3所得之液晶配向處理劑(3)及實施例7所得之液晶配向處理劑(7)係含有使特定四羧酸二酐及特定脂肪族四羧酸二酐之2種類的四羧酸二酐與二胺成分進行反應所得的特定聚合物者。具體而言,實施 例3之液晶配向處理劑(3)係與實施例2之液晶配向處理劑(2)同樣的構成,實施例7之液晶配向處理劑(7)係與實施例6之液晶配向處理劑(6)同樣的構成。 The liquid crystal alignment treatment agent (3) obtained in Example 3 and the liquid crystal alignment treatment agent (7) obtained in Example 7 contain two types of tetracarboxylic acid which are specific tetracarboxylic dianhydrides and specific aliphatic tetracarboxylic dianhydrides. A specific polymer obtained by reacting an acid dianhydride with a diamine component. Specifically, implementation The liquid crystal alignment treatment agent (3) of Example 3 has the same configuration as that of the liquid crystal alignment treatment agent (2) of Example 2, and the liquid crystal alignment treatment agent (7) of Example 7 and the liquid crystal alignment treatment agent of Example 6 (6). The same composition.

因此,使用實施例3之液晶配向處理劑(3)及實施例7之液晶配向處理劑(7),噴墨法所得之液晶配向膜,觀察上述電壓保持率之測定結果(實施例2、6)時,可推測為電壓保持率之降低被抑制,且具有優異的光耐性者。因此,對於具有噴墨法所得之液晶配向膜的液晶顯示元件,同樣地,即使處於長時間光照射,電壓保持率也不會降低,具有光耐性,且可靠性優異者。 Therefore, the liquid crystal alignment treatment agent (3) of Example 3 and the liquid crystal alignment treatment agent (7) of Example 7 were used, and the liquid crystal alignment film obtained by the inkjet method was observed, and the measurement results of the voltage holding ratio were observed (Examples 2 and 6). In the case of the above, it is presumed that the decrease in the voltage holding ratio is suppressed and the light resistance is excellent. Therefore, in the liquid crystal display element having the liquid crystal alignment film obtained by the inkjet method, in the same manner, even if it is irradiated with light for a long period of time, the voltage holding ratio is not lowered, and the light resistance is excellent, and the reliability is excellent.

Claims (6)

一種液晶配向處理劑,其特徵係含有選自使含有以下述式[1]表示之四羧酸二酐及下述式[2]表示之脂肪族四羧酸二酐的四羧酸成分與二胺成分進行反應所得之聚醯亞胺前驅物及將該聚醯亞胺前驅物進行醯亞胺化所得之聚醯亞胺之至少1種的聚合物, (式[2]中,Z1係選自下述式[2a]~式[2j]之至少1種的4價基) (式[2a]中,Z2~Z5表示氫原子、甲基、氯原子或苯環,各自可相同或相異;式[2g]中,Z6及Z7表示氫原子或甲 基,各自可相同或相異)。 A liquid crystal alignment treatment agent characterized by containing a tetracarboxylic acid component selected from the group consisting of a tetracarboxylic dianhydride represented by the following formula [1] and an aliphatic tetracarboxylic dianhydride represented by the following formula [2] a polyimine precursor obtained by reacting an amine component and at least one polymer of the polyimine obtained by subjecting the polyimine precursor to ruthenium imidization, (In the formula [2], Z 1 is selected from at least one tetravalent group of the following formula [2a] to formula [2j]) (In the formula [2a], Z 2 to Z 5 represent a hydrogen atom, a methyl group, a chlorine atom or a benzene ring, and each may be the same or different; in the formula [2g], Z 6 and Z 7 represent a hydrogen atom or a methyl group, Each can be the same or different). 如申請專利範圍第1項之液晶配向處理劑,其係含有N-甲基-2-吡咯烷酮(pyrrolidone)、N-乙基-2-吡咯烷酮或γ-丁內酯作為液晶配向處理劑中之溶劑。 The liquid crystal alignment treatment agent of claim 1, which comprises N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone or γ -butyrolactone as a solvent in a liquid crystal alignment treatment agent. . 如申請專利範圍第1項之液晶配向處理劑,其係含有選自下述式[D-1]~式[D-3]表示之溶劑的溶劑作為液晶配向處理劑中之溶劑, (式[D-1]中,D1表示碳數1~3之烷基,式[D-2]中,D2表示碳數1~3之烷基,式[D-3]中,D3表示碳數1~4之烷基)。 The liquid crystal alignment treatment agent according to the first aspect of the invention, which comprises a solvent selected from the group consisting of the solvents represented by the following formula [D-1] to the formula [D-3] as a solvent in the liquid crystal alignment treatment agent, (In the formula [D-1], D 1 represents an alkyl group having 1 to 3 carbon atoms, and in the formula [D-2], D 2 represents an alkyl group having 1 to 3 carbon atoms, and in the formula [D-3], D 3 represents an alkyl group having 1 to 4 carbon atoms). 一種液晶配向膜,其特徵係使用如申請專利範圍第1項之液晶配向處理劑所得者。 A liquid crystal alignment film characterized by using a liquid crystal alignment treatment agent according to claim 1 of the patent application. 一種液晶配向膜,其特徵係使用如申請專利範圍第1項之液晶配向處理劑,藉由噴墨法所得者。 A liquid crystal alignment film characterized by using a liquid crystal alignment treatment agent according to claim 1 of the patent application, which is obtained by an inkjet method. 一種液晶顯示元件,其特徵係具有如申請專利範圍第4或5項之液晶配向膜者。 A liquid crystal display element characterized by having a liquid crystal alignment film of item 4 or 5 of the patent application.
TW103106758A 2013-02-28 2014-02-27 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element TWI617622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013039877 2013-02-28

Publications (2)

Publication Number Publication Date
TW201500463A true TW201500463A (en) 2015-01-01
TWI617622B TWI617622B (en) 2018-03-11

Family

ID=51428303

Family Applications (1)

Application Number Title Priority Date Filing Date
TW103106758A TWI617622B (en) 2013-02-28 2014-02-27 Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element

Country Status (5)

Country Link
JP (1) JP6264577B2 (en)
KR (2) KR102470287B1 (en)
CN (1) CN105190415B (en)
TW (1) TWI617622B (en)
WO (1) WO2014133043A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180101453A (en) * 2016-01-07 2018-09-12 닛산 가가쿠 가부시키가이샤 Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3201172B2 (en) 1994-09-08 2001-08-20 ジェイエスアール株式会社 Liquid crystal alignment agent
JP3613421B2 (en) 1996-05-31 2005-01-26 Jsr株式会社 Liquid crystal alignment agent
JP3650982B2 (en) 1996-10-02 2005-05-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP3409022B2 (en) * 2000-06-30 2003-05-19 三山工業株式会社 Manhole wall fastener
JP2002131751A (en) * 2000-10-25 2002-05-09 Hitachi Chemical Dupont Microsystems Ltd Composition for liquid crystal aligning film, liquid crystal aligning film, liquid crystal holding substrate, liquid crystal display and horizontal electric field liquid crystal display
TWI276899B (en) * 2002-08-29 2007-03-21 Nissan Chemical Ind Ltd Material for liquid crystal alignment and liquid crystal displays using the same
CN101925851B (en) * 2008-01-25 2013-09-25 日产化学工业株式会社 Liquid-crystal alignment material and liquid-crystal display element
JP5884258B2 (en) * 2009-09-18 2016-03-15 Jnc株式会社 Liquid crystal aligning agent, liquid crystal aligning film, method for producing liquid crystal aligning film, and liquid crystal display element
US8741397B2 (en) * 2009-11-09 2014-06-03 Jnc Corporation Liquid crystal display element, liquid crystal composition, aligning agent, method for producing liquid crystal display element, and use of liquid crystal composition
JP5904121B2 (en) * 2010-07-26 2016-04-13 日産化学工業株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6052171B2 (en) * 2011-05-27 2016-12-27 日産化学工業株式会社 Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
CN103827211B (en) * 2011-07-12 2017-06-06 日产化学工业株式会社 Composition, aligning agent for liquid crystal, liquid crystal orientation film and liquid crystal display cells

Also Published As

Publication number Publication date
TWI617622B (en) 2018-03-11
WO2014133043A1 (en) 2014-09-04
CN105190415B (en) 2017-11-10
KR20200103879A (en) 2020-09-02
JPWO2014133043A1 (en) 2017-02-02
CN105190415A (en) 2015-12-23
KR20150122209A (en) 2015-10-30
KR102470287B1 (en) 2022-11-23
JP6264577B2 (en) 2018-01-24

Similar Documents

Publication Publication Date Title
TWI568796B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI628232B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
TWI650345B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI620791B (en) Polymer, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI564283B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI638008B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI513753B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TWI635135B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI654222B (en) Liquid crystal alignment treatment agent and liquid crystal display element using the same
JP6052171B2 (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI499588B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TWI649411B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI623518B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI624494B (en) Composition, liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
CN109791332B (en) Liquid crystal display element having curved liquid crystal panel and liquid crystal aligning agent used for same
TW201430054A (en) Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TWI628202B (en) Method for producing liquid crystal alignment film, liquid crystal alignment film, liquid crystal display element, and liquid crystal alignment agent
TWI617622B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element
WO2016076413A1 (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element
TWI588190B (en) Liquid crystal alignment treatment agent, liquid crystal alignment film and liquid crystal display element